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Abstract 
Preterm infants with very low birth weight (VLBW; birth weight ≤1500 g) suffer 
from a high risk of intra-ventricular hemorrhage (IVH) and other serious 
diseases. Even for those VLBW infants who survive, they still have a strong 
possibility of developing long-term neurodevelopmental disabilities. 
To improve the clinical risk assessment of preterm infants and develop potential 
clinical makers for the adverse outcome in preterm infants, the first part of the 
paper develops the frequency spectral analysis on the non-invasively measured  
heart rate variability (HRV), blood pressure variability (BPV) and cerebral near-
infrared spectroscopy (NIRS) measures. Moderate and high correlations with 
the clinical risk index for babies (CRIB II) were identified from various spectral 
measures of arterial baroreflex and cerebral autoregulation functions which 
provided further justification for these measures as possible markers of clinical 
risks and predictors of adverse outcome in preterm infants. It was also observed 
that the cross-spectral transfer function analysis of cerebral NIRS and arterial 
blood pressure (ABP) was able to provide a number of parameters that were 
potentially useful for distinguishing preterm infants with IVH from without IVH. 
Furthermore, the detrended fluctuation analysis (DFA) that quantifies the fractal 
correlation properties of physiological signals has been examined, to determine 
whether it could derive markers for the identification of preterm infants who 
developed IVH. The results have demonstrated that fractal dynamics embedded 
in the ABP waveform could provide useful information that facilitates early 
identification of IVH in preterm infants.  
Cardiac output (CO) and total peripheral resistance (TPR) are two important 
parameters of the cardiovascular system. Measurement of these two 
parameters can provide valuable information for the assessment and 
management of patients needing intensive care, including preterm infants in the 
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neonatal intensive care unit (NICU). The results of arterial blood pressure 
waveform analysis demonstrate that the diastolic decay rate had a significant 
positive relationship with CO and negative relationship with TPR.  To further 
assess the changes in CO and TPR in the preterm infants, the multivariate 
regression model based on the useful features from arterial blood pressure 
waveform analysis was used to improve the accuracy and robustness of the 
estimation. The combination of signal analysis and multivariate regression 
model in estimation of CO has produced some outcomes, and in the future, 
more effort should be involved in this kind of research to improve the prediction 
of serious diseases in preterm infants. 
Overall, this PhD research project has demonstrated that the features extracted 
from the cardiovascular waveforms by different signal processing methods, 
including frequency spectrum analysis, DFA and ABP waveform analysis, could 
provide potentially useful information for assessing clinical risks in the preterm 
infants. This represents an important step towards continuous monitoring and 
automatic detection of life threatening episodes in these infants. 
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Chapter 1. Introduction 
1.1 Research motivation 
Preterm infants with very low birth weight (VLBW; birth weight ≤1500 g) suffer 
from a high risk of serious diseases, such as intra-ventricular hemorrhage (IVH). 
Whilst the survival of these very low birth weight babies has continued to 
improve over the years, there is still a substantial risk of developing long term 
neurodevelopmental disability even with low grade IVH [1]. The timing of IVH 
indicates most hemorrhages develop after birth with such factors as 
resuscitation and cardiorespiratory management during the first 24 hours of life 
being important in the causal pathway [2]. Thus the ability to identify preterm 
infants with IVH at an early stage is of great importance in terms of minimizing 
mortality and morbidity in the neonatal intensive care setting. 
The need for identifying babies with high risk of critical pathological conditions 
such as IVH has motivated the development of clinical risk and disease severity 
scores for use in the neonatal intensive care setting. Amongst these scores, the 
Clinical Risk Index for Babies (CRIB) has gained wide acceptance 
internationally as a preferred method of quantifying mortality risk amongst very 
preterm infants, partly due to its simplicity in computation [3]. Whilst the original 
CRIB score required fractional inspired oxygen in the first 12 hours of life for its 
computation, an updated version of CRIB (known as CRIB II) was published in 
2003 [4]. CRIB II is scored at the first hour of life, based on a number of clinical 
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factors including birth weight, gestational age, gender, temperature on 
admission and blood base excess.       
The use of cerebral perfusion measurement to identify preterm infants with high 
risk of mortality or IVH has also been proposed [5-8]. The underlying premise 
was that impairment of cerebral autoregulation could be a potentially important 
cause of brain injury such as IVH.A popular technique of assessing cerebral 
autoregulation is by frequency domain cross-spectral transfer function analysis, 
with higher coherence (or correlation), reduced phase shift and/or higher gain 
between arterial BP and Cerebral blood flow (CBF) being regarded as possible 
indication of impaired autoregulation [9-11]. In this research, I examined how 
various measures derived from spectral and cross-spectral analysis of arterial 
blood pressure (BP) and cerebral near-infrared spectroscopy (NIRS) were 
related to CRIB II, which would help to establish these measures as potential 
indicators of clinical risk in preterm infants. 
Furthermore, the various parameters derived from cross-spectral transfer 
function analysis of arterial BP and cerebral NIRS have been examined whether 
they could demonstrate significant difference between preterm infants with and 
without IVH. In contrast to previous studies which adopted a single NIRS 
measure: tissue oxygenation index (TOI) or hemoglobin difference (HbD) as a 
surrogate of CBF, we examined the transfer function relationships of arterial BP 
to a number of NIRS measures to understand which of the measures might be 
more useful for the detection of IVH.  
With the improvements in neonatal intensive care, the incidence of IVH has 
fallen in preterm infants with very low birth weight [12]. Rates of particularly 
severe grades of IVH with extension into cerebral tissue (grade V IVH) in the 
Papille system are still a major attention on those extremely preterm infants  
[13]. It was hoped that the new method might provide a better time resolution of 
the events immediately before and after the severe grades of IVH, allowing 
clearer views on the precise timing relationship of the multiple clinical 
parameters during the occurrence of IVH. The early detection of IVH will 
present an important step in minimizing mortality and morbidity in the neonatal 
intensive care setting [14], [15].  
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Detrended fluctuation analysis (DFA) has been regarded as a robust method to 
quantify the scale-invariant (fractal) correlation property of a time series, 
especially when the signal class cannot be precisely determined. Specifically, 
this method characterises the mono-fractal property. Previous studies have 
adopted this method to evaluate the fractal dynamics of heart rate in various 
diseases in adult subjects [16, 17]. The DFA method aims at measuring the 
intrinsic fractal-like correlation properties or self-affinity of the time series, 
characterized by increasing magnitude of fluctuations with increasing time scale 
(or decreasing frequency). 
Assessment of fractal scaling properties in ABP in adult humans based on DFA 
method has also been reported [18-20]. It was therefore suggested that fractal 
dynamics of arterial pressure were largely influenced by the autonomic nervous 
system activity. However, the fractal scaling of arterial BP in preterm infants has 
not been investigated previously. In this study, I examined whether there was a 
difference in fractal scaling exponents derived from DFA method of arterial BP 
between preterm infants with and without IVH. It was hypothesized that the 
infants who developed IVH might have higher fractal scaling exponents of 
arterial BP, similar to that seen in heart rate fluctuations [21]. The findings could 
help to establish the potential value of fractal dynamics embedded in the arterial 
pressure waveform for early identification of brain hemorrhage in preterm 
infants. 
CO and TPR are two important parameters of the cardiovascular system. 
Measurement of these two parameters can provide valuable information for the 
assessment and management of patients needing intensive care, including 
preterm infants in the NICU [22, 23]. Furthermore, the measurement of systemic 
hemodynamics can facilitate the development of better therapeutic strategy for 
these infants, including the use of volume expansion and inotropes [23]. In the 
present NICU setting, the assessment of CO and TPR requires the 
measurement of left ventricular outflow (LVO) or right ventricular outflow (RVO) 
using ultrasound Doppler echocardiographic waveforms. The clinical method for 
CO measurement should be accurate, continuous, inexpensive and minimally 
invasive. However, such conventional monitoring requires specialized skill and 
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equipment, and cannot be performed continuously and invasively. However, 
none of the CO measurement methods possess all of these characteristics and 
can be widely used in the clinical diagnosis for preterm infants. For example, 
the thermodilution method does not operate continuously and requires a 
pulmonary artery catheterization whose safety and accuracy has been 
questioned.  
In this study, the estimation of LVO and TPR was performed by analyzing the 
rate of blood pressure decay in the diastolic portion of the arterial pulse wave. 
This has been associated with TPR in the Windkessel model, and has been 
utilized in the study of animals and adult patients [24, 25].However, whether this 
arterial waveform parameter is useful for monitoring preterm infants has not 
been previously investigated. The results from the current study would help to 
establish the potential utility of the diastolic decay rate parameter for assessing 
LVO and TPR in preterm infants. Then, the diastolic decay rate and BP features 
are added as input features to a multivariate regression model to estimate LVO 
and TPR. A stepwise feature search algorithm was employed to select 
statistically significant features. K folded cross validation was used to assess 
the generalized model performance. The degree of agreement between the 
estimation method and the real measurement of LVO and TPR was assessed 
using Bland- Altman analysis.  
1.2 Objectives 
With the motivations highlighted in the previous section, the current work aims 
to achieve the following three objectives: 
 To develop signal processing tools to detect IVH using ECG, NIRS and 
blood pressure signals in preterm infants. 
 To develop signal processing tools to identify parameters that reflect 
clinical risk (CRIB II score): the relationships between CRIB II and 
various spectral measures of arterial baroreflex and cerebral 
autoregulation functions are possible markers of clinical risks and 
predictors of adverse outcome in preterm infants. 
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 To identify parameters that can detect change in cardiac output (left 
ventricular outflow LVO) and TPR over time which cannot be measured 
continuously in current clinical setting but are useful for identifying clinical 
risk. 
 To develop a mathematical model to estimate CO and TPR using ABP 
waveform. 
1.3 Paper contributions 
The contributions of this paper are: 
 This paper demonstrates that cerebral NIRS measurement was able to 
provide a number of parameters that were potentially useful for 
distinguishing between preterm infants with or without brain hemorrhage.  
 This study is the first to examine the fractal dynamics of arterial BP in 
preterm infants using the DFA approach. The rationale was to address 
whether the fractal scaling of arterial BP could provide potentially useful 
information for distinguishing between preterm infants with and without 
brain hemorrhage. 
 This paper firstly establishes the link between parameters derived from 
spectral analysis of systemic and cerebral cardiovascular variabilities and 
clinical risk of preterm infants, via examining the correlation of these 
parameters with the CRIB II score.  
 This paper provides potentially useful information for continuous 
monitoring clinical risks in the preterm infants by the utility of arterial 
pressure waveform analysis for estimating LVO and TPR in preterm 
infants.  
1.4 Paper organization  
The rest of this paper is organized as follows: 
 Chapter 2 provides the background information associated with the 
current work and a brief literature review of previously developed 
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monitoring and signal analysis tools utilized in clinical monitoring of 
preterm infants. 
 Chapter 3 presents the potential use of spectral analysis of heart rate, 
blood pressure and cerebral NIRS as a monitoring tool to assess the 
mortality and mobility in preterm infants. It has two parts: (1) 
Development of a potentially useful method from transfer function 
analysis to distinguish between preterm infants with or without IVH; (2) 
Development of the cross spectrum analysis to find out the potential 
relationship with CRIB II by linear regression approach. 
 Chapter 4 develops the Detrended fluctuation analysis of blood 
pressure in preterm infants to compare between preterm infants with and 
without IVH. 
 Chapter 5 presents a method to continuously and noninvasively 
estimate CO and TPR in Preterm Infants by Arterial Waveform Analysis 
and a multivariate regression model. 
 Chapter 6 summarizes the work presented in this paper and presents 
some future directions which can be pursued to advance the assessment 
of clinical risks in preterm infants. 
1.5 Author's publications  
The work presented in this paper was published in the following papers, which 
have been produced by the author during her PhD candidacy: 
Journal publications 
 Y. Zhang, G.S.H. Chan,  M.B. Tracy, Q.Y. Lee, M. Hinder, A.V. Savkin, 
and N.H. Lovell, "Spectral analysis of systemic and cerebral 
cardiovascular variability in preterm infants: relationship with Clinical Risk 
Index for Babies (CRIB)" ,Physiological Measurement, 32:1,931 – 1,928, 
2011. 
 Y. Zhang, G.S.H. Chan,  M.B. Tracy, M. Hinder, A.V. Savkin, and N.H. 
Lovell, "Detrended fluctuation analysis of blood pressure in preterm 
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infants with intraventricular hemorrhage", Medical & Biological 
Engineering & Computing, 51:1051-1057, 2013. 
Peer reviewed conference publications 
 Y. Zhang, G.S.H. Chan,  M.B. Tracy, Q.Y. Lee, M. Hinder, A.V. Savkin, 
and N.H. Lovell,  "Cerebral near-infrared spectroscopy analysis in 
preterm infants with intraventricular haemorrhage",33rd Annual 
International Conference of the IEEE Engineering in Medicine and 
Biology Society , Boston, USA, pp 1937 – 1940,2011. 
 Y. Zhang, G.S.H. Chan,  M.B. Tracy, M. Hinder, A.V. Savkin, and N.H. 
Lovell,, "Estimation of Cardiac Output and Systemic Vascular Resistance 
in Preterm Infants by Arterial Waveform Analysis" 34rd Annual 
International Conference of the IEEE Engineering in Medicine and 
Biology Society, Osaka, Japan, pp 2308-2311, 2013. 
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Chapter 2. Background and Literature 
Review 
2.1 Preterm infants and their clinical management 
 
Very preterm infants are at high risk of death, 53% of the babies born before 24 
weeks  can survive but the survival rate increases dramatically to 93% after 27 
weeks gestation in 2011 [26].The birth weight is another important factor to 
survival rate, the same tendency is demonstrated in the survival rate rise from 
less than 60% with birth weight ≤ 500 g to more than 90% at birth weight ≥ 1250 
g [26]. 
A dramatic decline in mortality rates in preterm infants could be attributed to 
advances in neonatal intensive care and specialized obstetric, including  
exogenous surfactant administration to babies from the late 1980s, and the 
growing utilization of antenatal corticosteroids from the early 1990s [26],[27]. 
Although the survival rate increased because of major advancements in 
neonatal intensive care, the preterm infants still have high risk of serious 
permanent brain damage and disturbances in brain maturation, as occurs with 
intra-ventricular haemorrhage (IVH).The rates of most major neonatal 
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morbidities have remained unchanged in the past decade since the survival rate 
of smaller and less mature infants initially increased[28]. 
The brain damage will leads to atypical brain development and long term 
neurodevelopmental disabilities even with low grade IVH [29].Accordingly, 
preterm infants have a strong possibility of developing motor disabilities 
including cerebral palsy persist, as well as less prominent developmental 
disabilities in cognition, social, language and behaviour [1, 29, 30].With the 
improvement of intensive care, mortality rate is not the only important adverse 
consequence of preterm infants, more and more attention has been paid on 
reducing morbidity including brain injury [31].Improved understanding of the risk 
factors for acquired brain injury and associated factors that 
affect brain development in this population is setting the stage for improving 
the brain health of children born preterm. 
2.1.1 Intra-ventricular Haemorrhage 
IVH is the most commonly diagnosed brain lesion in the preterm infants [28] 
and potentially relates to significant lifelong sequelaes and serious neonatal 
complications [5]. There is evidence in the past showing that the periventricular 
leukomalacia (PVL) and posthemorrhagic hydrocephalus (PHH) are two 
significant sequelae of IVH [32]. According to the location and severity of the 
PVL lesions, the clinical presentation of sicked infants may include decreased 
visual fields, spastic diplegia and cognitive impairment [33, 34]. Similar 
investigations have also been reported that the white matter injury which follows 
IVH reflects the leading cause of the neurodevelopmental impairments suffered 
by preterm infants.  
The head ultrasound is generally used to detect signs of IVH during the first 
week after the babies were born [26]. The commonly used method to define IVH 
grade was first reported by Papile et al in 1978,  in which IVH severity increases 
with higher grade [13].  The IVH grades was classified into 4 grades, from I to IV, 
including grade I, haemorrhage confined to the subependymal germinal matrix; 
grade II, haemorrhage into the lateral ventricles without ventricular dilatation; 
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grad-e III, IVH with ventricular dilation; and grade IV, IVH with parenehymal 
haemorrhage into cerebral tissue [28].  
With the advancements in neonatal intensive care, the incidence of IVH has 
fallen from 30% in the 1980’s to 6 % [12] in preterm infants with very low birth 
weight (birth weight ≤1500 g). However recent report has indicated that the 
rates of IVH have remained at 20% to 70% for extremely preterm infants (<27 
weeks gestation) [26]. Rates of IVH and in particularly severe grades of IVH 
with extension into cerebral tissue (grade V IVH) in the Papille system are still a 
major concern in those extremely preterm infants (<27 weeks gestation) [13]. 
Fragile cerebral circulation of preterm infants is affected by fluctuations in the 
systemic circulation associated with the pathophysiology of preterm birth and 
the first six hours of life when complex interactions occur between mechanical 
ventilation and the circulation. Preterm birth <27 weeks is an abnormal event 
often precipitated by maternal infection, bleeding or hypertension, factors all 
predisposing to reduced uterine perfusion and thus placental function. Placental 
dysfunction is a predisposing factor to the fragile blood vessels in the germinal 
matrix bleeding in a grade I IVH. If this extends into the ventricular system 
(grade II IVH) and then blocks the needed drainage of ventricular fluid via the 
third and fourth ventricles (grade III IVH), risks of long-term brain damage rise. 
Venous occlusion in adjacent areas of the cerebral hemispheres can give rise to 
infarction and significant injury to major motor tracks leading to cerebral palsy or 
intellectual impairment [1, 30]. 
The timing of IVH indicates most haemorrhages develop after birth with such 
factors as resuscitation and cardiorespiratory management during the first 24 
hours of life being important in the NICU [35],[36]. Thus the ability to identify 
preterm infants with IVH at an early stage is of great importance in terms of 
minimizing mortality and morbidity in the neonatal intensive care setting. 
2.1.2 Clinical Risk Index for Babies  
The need for identifying babies with high risk of critical pathological conditions 
such as IVH has motivated the development of clinical risk and disease severity 
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scores for use in the neonatal intensive care setting. Amongst these scores, the 
CRIB  has gained wide acceptance internationally as a preferred method of 
quantifying mortality risk amongst very preterm infants, partly due to its 
simplicity in computation [3]. It was implemented with data relating to infants of 
birth weight ≤1500 g or infants born ≤ 31 weeks, treated in neonatal intensive 
care between 1988 and 1990 [3]. 
Survival of VLBW infants depends on birth weight (BW) and gestational age 
(GA), but also on other physiological conditions and perinatal factors of the 
individual infants. Disease severity scores were developed to compare the risk 
of mortality between different NICUs, since the sicker infants may still have 
higher mortality despite with better care in hospital. CRIB Scores are calculated 
from gestational age, birth weight, maximum and minimum appropriate fraction 
of inspired oxygen (FiO2), maximum base excess and presence of congenital 
malformations at the first 12 hour after birth [37].Therefore, it is more closely 
related to mortality and impairment after intensive care than the BA.Whilst the 
original CRIB include the data at in the first 12 hours of life with possible 
neonatal treatment bias, its appropriateness in prediction of mortality have been 
questioned. Furthermore, original CRIB score required FiO2 in the first 12 hours 
of life for its computation, which is not a true clinical measure decided by the 
neonatal care team [27].  
2.1.3 Estimating Left Ventricular Outflow  
The ability to measure Cardiac Output parameters continuously and 
noninvasively can provide valuable information for the assessment and 
monitoring of the potential cardiovascular diseases or other critical illnesses, 
including preterm infants in the neonatal intensive care unit (NICU)  [22, 23].For 
example, high CO is the symptom of sepsis, which is a common cause of 
mortality and morbidity in preterm infants, particularly those with VLBW [22]. A 
substantial drop in CO (>50%) has been associated with a high risk of mortality 
in these infants with sepsis [22]. Furthermore, the measurement of systemic 
hemodynamics can facilitate the development of better therapeutic strategy for 
these infants, including the use of volume expansion and inotropes [23].  
12 
 
In the present NICU setting, the assessment of CO and TPR requires the 
measurement of left ventricular outflow or right ventricular outflow using 
invasive or non-invasive methods. In this study , LVO was obtained invasively 
by measuring the aortic valve annulus diameter in the parasternal long axis 
view, and then velocity time integrals (VTI) were obtained with a minimum of 5 
consecutive aortic pulsed Doppler waveforms from an apical long axis view  [38]. 
2.2 Technique for preterm infants monitoring  
2.2.1 Near-infrared spectroscopy  
Near infrared spectroscopy (NIRS) measurements were first utilized in 
pediatrics for the bedside monitoring of cerebral oxygenation in sick preterm 
infants by Brazy and Lewis [39]. Then this technology was used for the 
monitoring of cerebral oxygenation and hemodynamics during congenital heart 
surgery by Greeley et al. [40] . With the improvements in neonatal intensive 
care setting, neurologic overcomes have surpassed mortality as the primary 
problems in preterm infants. Therefore the use of NIRS measurements to 
monitor cerebral circulation and enhance detection of brain injury has gained 
widespread acceptance.  
Cerebral NIRS data were collected by measuring tissue absorbance of light at 
different wavelengths from 700-1000 nm [41]. Because near infrared light can 
penetrates biological tissues and even bone, NIRS measurements can be 
performed through the intracranial compartment. In this study, cerebral NIRS 
data were measured by the NIRO-300 system (Hamamatsu Photonics, 
Hamamatsu City, Japan), with the sensor probe placed over the skin of the 
temporoparietal region on the head of the infant. The instrument transfers laser 
diode light by a fiber optic bundle to the head and thereby to the intracranial 
compartment [42].The sensor probe of the NIRS-300 monitor consists of a fiber 
optic probe that emits four wavelengths of near-infrared light (775, 825, 850 and 
904 nm), and a receiver probe made of separate aligned photodetectors, which 
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permit the measurement of spatially resolved NIRS. The NIRS parameters are 
computed by the device every 0.167 s (6 Hz).  
Cerebral / Brain oxygenation information by NIRS includes the indices as 
follows: 
 Oxygenated haemoglobin change (HbO2) 
 Deoxygenated haemoglobin change (HHb) 
 Total haemoglobin change (cHb) 
 Tissue oxygenation index (TOI): TOI= 
    
        
                
 Normalized tissue haemoglobin index (THI) 
 Fractional tissue O2 extraction (FTOE): FTOE =
        
    
 
 Hb difference (HbD) : HbD = HbO2 – HHb 
Previous clinical study indicated that disturbances in CBF were important in the 
pathogenesis of IVH. In a healthy brain, the cerebral auto-regulation mechanism 
normally acts to limit the variation in CBF over a range of perfusion pressure, so 
as to protect the brain from large fluctuations in CBF [43, 44]. However, 
impairment of this protective mechanism will increase the risks of 
cerebrovascular injury and brain haemorrhage [5-8].The preterm infants often 
suffer from disturbances in CBF for two major reasons: First, because of the 
high incidence of respiratory disease, they need mechanical ventilation, 
therefore alterations in mean arterial blood pressure (MAP) are very common in 
such infants. Second, various studies indicate that cerebral auto-regulation is 
either defective or absent in some preterm infants [42]. To measure CBF and 
find out the indication of impaired cerebral auto-regulation for preterm infants, 
the xenon-133 clearance technique was first proposed by in 1979 by Lou et al. 
[45]. Subsequent study has shown a clear relationship between impaired 
autoregulation and the incidence of IVH [46, 47].However, the xenon-133 
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clearance technique to monitor CBF involves radiation exposure and cannot be 
used to continuously detect the impaired cerebral autoregulation[42]. 
For the monitoring of preterm infants, the NIRS has been preferred for deriving 
surrogate measures of CBF changes, given its ability to provide simple, non-
invasive and comfortable continuous measurement. The NIRS technique can 
quantify changes in cerebral oxygenation and haemoglobin content, such as the 
oxygenated haemoglobin (HbO2), the deoxygenated haemoglobin (HHb), and 
the tissue oxygenation index (TOI) )(which is ratio of HbO2 to total hemoglobin 
HbO2+HHb) that reflects oxygen saturation in brain vasculature (predominantly 
in the venous compartment, which represents ~75% of total cerebral blood 
volume [48]). The TOI was found to reflect CBF variations during reduction in 
perfusion pressure, under the conditions of constant arterial oxygen saturation 
and cerebral oxygen consumption [49]. Some investigators also derived the Hb 
difference (HbD [5-7, 50], which was shown to be correlated with CBF during 
hypotensive episodes [50].  NIRS also provides measures of the fractional 
tissue oxygen extraction (FTOE), which is the ratio of cerebral oxygen 
consumption to oxygen delivery.  
2.2.2 Updated Clinical Risk Index for babies  
An updated version of CRIB (known as CRIB II) published in 2003 introduced a 
simplified and re-adjusted scoring system, which avoids the potential problems 
because of the use of FiO2 and data up to 12 hours after born [27].  The CRIB II 
score is not only a risk-adjustment instrument widely used in NICUs to measure 
initial illness severity, but also a predictor of mortality and morbidities until 
discharge. It was based on the first hour findings, therefore there is less 
treatment bias compared with CRIB score.  
CRIB II score is calculated on a number of clinical factors including birth weight, 
gestational age, gender, temperature on admission and blood base excess. It 
has a greater discriminatory ability to predict mortality than do other scoring 
systems. Extremely preterm infants with higher overall CRIB-II scores are more 
likely to have major disability and poor outcome. 
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The initial condition of the neonates within the first hour of life does not remain 
stable throughout their hospitalization. Three components of the CRIB-II score 
(gestational age, birth weight and gender) do not change after birth. However, 
two components (body temperature and blood base excess) are changeable, so 
a high CRIB-II score can remind caregivers to optimize these factors as early as 
possible; if rectified in a timely manner, the immediate and longer-term impact 
may be reduced. Currently the CRIB-II score is mainly used to compare 
mortality and morbidities within NICUs and does not provide individual 
prediction accurately enough for diagnosis. 
Clinical parameters, such as birth weight, gestational age and cranial ultrasound 
have been separately used to predict long-term outcomes in preterm infants. 
However, these individual predictors do not have very good sensitivity and 
specificity compared with a composite scoring system [37]. 
The impact of major disability in preterm infants is lifelong. Identifying infants at 
risk of major disability allows earlier follow-up and intervention that may reduce 
the impact of the disability. It have been reported that that a CRIB-II score of 13 
maximizes sensitivity and specificity for predicting major disability, indicating a 
high likelihood of identifying infants at risk of major disabilities using this cut-off 
score. CRIB-II can be a useful tool for identifying preterm infants for follow-up or 
early-intervention programs.Nevertheless it should be noted that CRIB II score 
is a static and one-off measurement, it cannot be used to continuously monitor 
the conditions of infants in real time. 
2.2.3 Cardiovascular data  
In the last decade, significant interest in non-invasive monitoring of the 
cardiovascular system through the analysis of cardiovascular signals, such as 
Electrocardiogram (ECG) and ABP, has been generated in biomedical research 
community worldwide. The variability inherent within the ECG, for instance, has 
been proposed to implicate the increasing regularity representing pathological 
changes. Both of ECG and ABP represent cardiovascular control. 
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Cardiovascular variability, such as heart rate variability and blood pressure 
variability has emerged as potential non-invasive markers of autonomic nervous 
modulation (sympathetic and vagal nerve activities) and vasomotor regulation 
mechanisms [51, 52]. Frequency spectral analysis of beat-to-beat fluctuation of 
heart rate (HR) has been proven to be a useful non-invasive tool for monitoring 
the variations of sympathovagal balance controlling HR [52].While similar 
investigations have also been reported by Andriessen et al.,  using transfer 
function analysis of HRV and BPV to quantify baroreflex sensitivity [53]. 
Compared with the conventional pharmacological method, the transfer function 
analysis is focused on analysis of spontaneous fluctuations in BP and HR, 
therefore it can be used to continuously monitor baroreflex function. It has also 
been suggested that the higher gain or coherence in the cerebral pressure-flow 
relationship could reflect impairment of CBF control by dynamic cerebral 
autoregulation, thus potentially linked with brain injury, such as IVH, or other 
mortality risk factors [5-8]. In this study, particular interest was given to the 
changes in baroreflex control of HR before and after the occurrence of IVH in 
preterm infants, which were analysed by power spectrum and transfer function 
analysis of HRV and BPV. 
The sympathetic and vagal nerve fluctuations in HR may be independently 
affected by some disorders of autonomic nervous system.Disorders of the 
central and peripheral nervous system have effects on HRV [54]. It has been 
reported that all normal cyclic fluctuations in HR are decreased in the presence 
of severe brain damage [55]. Although the accuracy of HRV was questioned, it 
was easily accessible to provide the neurologic information [56].  
2.3 Potential application of cardiovascular signals  
2.3.1 Frequency Spectrum Analysis 
Frequency spectral analysis provides the opportunity to decompose 
spontaneous fluctuations in blood pressure and cardiovascular signals into a 
power spectrum, and to relate the character of the fluctuations to physiological 
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processes. It has been proposed by Tang et al. to apply frequency spectral 
method to monitor the hemodynamic changes of cardiovascular system along 
the progression of sepsis [57]. Frequency spectral method has also been used 
in beat-to-beat fluctuation of HR, which  was proven to be a useful tool for 
noninvasively monitoring the variations of sympatho-vagal balance [58]. 
Cross-spectral transfer function analysis can provide information related to the 
regulation of cerebral blood flow by examining the relationship between arterial 
blood pressure and CBF fluctuations in the frequency domain [9]. The 
calculation of coherence was used to identify the potential source of the 
oscillations seemed in the heart rate variability and photoplethysmographic 
(PPG) waveforms [59]. 
Previous studies have suggested that Low-frequency (LF) fluctuations at a 
frequency of approximately 0.1 Hz related to the Baroreceptor reflex (BR) 
activity and high-frequency (HF) fluctuations are bound up with vagal 
modulation and respiratory activity [60] . Cross-spectral analysis between BP 
and RR interval fluctuations in the LF band (0.04–0.15 Hz) has been shown to 
be an estimate of the baroreceptor reflex sensitivity (BRS) [61-64]. Previously, 
the feasibility of using cross-spectral analysis to estimate BRS from 
spontaneous BP and RR interval fluctuations has been investigated in stable 
preterm infants [60]. 
The previous report investigated that the impairment of cerebral auto-regulation 
could be a potentially important cause of brain injury such as IVH [5-8]. The use 
of cerebral perfusion measurement to identify preterm infants with high risk of 
mortality or IVH has been proposed [5-8]. In a healthy brain, the cerebral auto-
regulation mechanism normally acts to limit the variation in CBF over a range of 
perfusion pressure, so as to protect the brain from large fluctuations in CBF [43, 
44]. Impairment of this protective mechanism, however, may lead to CBF being 
more dependent on changes in ABP, or more “pressure passive”, such that 
large changes in BP would be translated to large CBF fluctuations, hence 
increasing the risks of cerebrovascular injury and brain haemorrhage [5-8]. 
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A popular technique of assessing cerebral auto-regulation is by frequency 
domain cross-spectral transfer function analysis, with higher coherence (or 
correlation), reduced phase shift and/or higher gain between arterial BP and 
CBF being regarded as possible indication of impaired auto-regulation [9-11]. 
Some investigators also derived the Hb difference (HbD) as HbO2 – HHb [5-7, 
50], which was shown to be correlated with CBF during hypotensive episodes 
[50]. The transfer function analysis of BP and cerebral NIRS measures has 
demonstrated that alterations in dynamic cerebral auto-regulation properties, 
such as higher coherence or gain, are linked with IVH or other mortality risk 
factors [5-8]. 
The baroreceptor reflex (BR) is another important short-term regulatory 
mechanism of BP and heart rate (HR), which buffers or opposes sudden 
changes in systemic BP by regulating HR and peripheral vascular resistance 
[65]. BR sensitivity (BRS) is a crucial index to describe the BR regulation on BP 
and is classically defined as reflecting the degree of change in HR for a given 
unit change in BP [65]. Classical methods to measure BRS implements an 
external stimulus, such as infusion of vasoactive drugs [66] and mechanical 
pressure neck chamber [67]. New techniques to evaluate the BRS are based on 
the frequency and time domain analysis of BPV and HRV.Spectral technique 
that is commonly used to assess arterial BRS is founded on the cross-spectral 
transfer function calculation of BPV and HRV. The application of this technique 
in arterial baroreflex modulation of autonomic tone was widely utilized and has 
been reported in the past researchers [51, 53, 68]. Analysis of BPV and HRV 
showed a reduced cardiac BRS in adult patients with acute intra-cerebral 
haemorrhage, with BRS being able to predict adverse outcomes [69]. Whether 
BRS was related to clinical risks in preterm infants was not known, although a 
recent study found positive correlation between LF BRS gain and postmenstrual 
age (gestational age + postnatal age) [53], suggesting that low BRS in the high 
risk very preterm infants would be likely. 
The Welch method was used, which involved averaging the cross power 
spectra from multiple sub-segments in a similar fashion as the computation of 
Power Spectrum density (PSD). With the pre-determined auto spectra of signals 
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x and y in frequency f representation (i.e.,        and       respectively), the 
auto power spectra of signals x and y were each defined as Pxx(f) =|      |
 and 
Pyy(f) |      |
 
(f represents frequency). The cross power spectrum of x-y as 
Pxy(f) is calculated as the product of Pxx(f) and Pyy(f), the transfer function of x-y 
(from x to y) was computed as follows, 
     
      
      
                                                                                         (2.1)                              
From the equation 2.1, the magnitude and phase angle of the transfer function 
could be obtained accordingly and the BRS is the magnitude of the transfer 
function as follows: 
    |    |  √    [    ]      [    ]                                               (2.2) 
The magnitude-squared coherence function was defined as follows: 
      
|      | 
            
                                                                                           (2.3) 
BRS obtained through the transfer function analysis can be readily calculated 
for the coherence    which assesses the linear correlation between spectral 
components in the two signals, with a value ranging from 0 (lack of linear 
correlation) to 1 (perfect linear relationship). 
2.3.2 Nonlinear analysis 
There are several factors that influence heart rate, including respiration and 
mental load. HR regulation is a complex system in humans and the simplified 
model of HR regulation is shown in Figure 2-1.The sinus node, generating the 
HR is governed by sympathetic and parasympathetic efferents as well as 
several humoral factors.   
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Figure 2-1: A simplified model of HR regulation[70] 
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The sinus node works as the final factor of sympathetically and 
parasympathetically mediated stimuli and the procedure is reflected in the 
actual beat-to-beat interval [17]. The regulatory subsystems result in a scale-
invariant cardiac control according to different time scales, showing long-range 
correlations with a typical scaling behavior [17]. Therefore, the classical linear 
signal analysis methods are not often adequate to present the relevant 
properties of non-linear systems.  
Nonlinear analysis of HRV changes provides the new indices to quantify the 
complexity of fractal dynamics and stimulates innovative research into 
cardiovascular dynamics. Methods derived from nonlinear analysis of HRV have 
been proposed for clinical risk assessment of cardiovascular diseases, like 
sample entropy, sample asymmetry and detrended fluctuation analysis [17]. 
Sample entropy analysis of HRV has been used to estimate the complexity of 
cardiovascular dynamics. It has reported that the entropy falls before clinical 
signs of neonatal sepsis but the major mechanism is not related to the regularity 
of the data because of the presence of spikes [71]. The limitation of sample 
entropy analysis is the requirement of stationarity and the adverse affect of 
missed beats or artefacts [71]. 
DFA method has been regarded as a robust method to quantify the scale-
invariant (fractal) correlation property of time series, especially when the signal 
class cannot be precisely determined. Specifically, this method characterises 
the mono-fractal property. Previous studies have adopted this method to 
evaluate the fractal dynamics of heart rate in various diseases in adult subjects 
[16, 17]. The DFA method aims at measuring the intrinsic fractal-like correlation 
properties or self-affinity of the time series, characterized by increasing 
magnitude of fluctuations with increasing time scale (or decreasing frequency). 
The degree of fractal scaling can be depicted by the scaling exponent (α) that 
quantifies the relationship between fluctuations F(n) and time scale n based on 
the mathematical function F(n) = Cnα, with α = 1 corresponding to the classical 
1/f fractal signal [16, 17]. In a prior study, preterm infants who later developed 
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IVH were found to have significantly higher short-term scaling exponent of heart 
rate compared with those who did not develop IVH [21]. The differing fractal 
dynamics of heart rate in these two groups of infants have been attributed to the 
altered autonomic control of the heart associated with the development of IVH. 
Assessment of fractal scaling properties of ABP in adult humans, which is 
based on the DFA method has also been reported [18-20]. By performing 
autonomic blockade tests, it was shown that vagal blockade by atropine could 
lead to an increase in the short-term scaling exponent of BP, whereas central 
blockade of both cardiac and vascular sympathetic outflow by clonidine would 
result in a decrease of the exponent [20]. It was therefore suggested that fractal 
dynamics of arterial pressure were largely influenced by the autonomic nervous 
system activity. However, the fractal scaling of arterial BP in preterm infants has 
not been investigated previously.  
2.3.3 Arterial waveform analysis 
While the current measurement of CO cannot fulfil all the requirements of 
patients cohorts, analysis techniques to monitor CO from ABP waveforms may 
be achieved reliably and continuously with little or no invasiveness via radial 
artery catheterization and arterial tonometry [72], because ABP is related to CO 
through the arterial tree [24]. Previous work has also shown that arterial tree is 
represented by Windkessel model which comprises two parameters: arterial 
compliance (AC) and TPR of the small arteries as shown in Figure 2-2 
(left).ABP decays like a pure exponential during each diastolic interval with a 
time constant  , which equals to TPR·AC .Because AC is total compliance of 
the large arteries and  is nearly constant over a wide pressure range [73-76] , 
CO could then be measured within a constant scale. Thus, the technique was 
proposed by Bourgeois et al. to be conducted in fitting an exponent function to 
the diastolic interval of each ABP pulse in order to measure   [24].   
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Figure 2-2: The technique of Bourgeois et al. for monitoring CO from an ABP 
waveform [24, 77].  
 
2.4 Disease Prediction  
Increasing survival rate of premature infants has produced a focus change from 
mortality to morbidity, such as brain injury. The discovery and validation of 
potential indicators of brain injury and clinical risk is a critical step in the 
evolution of neonatal care [31].  
2.4.1 IVH detection  
Preterm birth <27 weeks is an abnormal event often precipitated by maternal 
infection, bleeding or hypertension, factors all predisposing to reduced uterine 
perfusion and thus placental function. It has been reported that IVH is an 
important predictor of adverse neurodevelopmental outcome [78].Both of the 
gestational age and medical risk factors are equally important predictors of 
neurologic outcome, especially in Grade 3-4 IVH [79-87]. In the newborn period, 
5-10% of preterm infants with Grade 3- 4 IVH suffer seizures and 50% of them 
have posthemorrhagic hydrocephalus [88]. As a result, mortality is higher in 
preterm infants with Grade 3-4 IVH have a higher mortality rate than those who 
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have the same gestational without Grade 3-4 IVH [89]. While preterm infants 
with Grade III-IV IVH have high risk of mental retardation and cerebral palsy [88, 
90-96], babies with Grade I - II IVH are also at risk for developmental disability 
[78]. Furthermore, a recent review found that 45- 86% of preterm children with 
Grade 3- 4 IVH have suffered from major cognitive handicaps, approximate75% 
of them need the special education [78, 90, 97]. Placental dysfunction is a 
predisposing factor to the fragile blood vessels in the germinal matrix bleeding 
in a grade I IVH. If this extends into the ventricular system (grade II IVH) and 
then blocks the needed drainage of ventricular fluid via the third and fourth 
ventricles (grade III IVH), risks of long-term brain damage rise. Venous 
occlusion in adjacent areas of the cerebral hemispheres can give rise to 
infarction and significant injury to major motor tracks leading to cerebral palsy or 
intellectual impairment [1, 30].The principal diagnostic procedure used to 
identify IVH in preterm infants is cranial ultrasonography. However, the cerebral 
ultrasound has not been used extensively in clinical settings because of special 
skills. 
IVH is most commonly developed within the first 24 hours after birth with such 
factors as resuscitation and cardiorespiratory management [35],[36], and 
haemorrhages can progress over 48 hours or more [78]. By the end of the first 
week after birth, 90% of the haemorrhages can be detected at their full extent 
[78]. Thus the ability to identify preterm infants with IVH at an early stage is of 
great importance in terms of minimizing mortality and morbidity in the neonatal 
intensive care setting. It is widely accepted that IVH has generally been 
attributed to variations in CBF to the immature germinal matrix microvasculature 
[78]. Cross-spectral transfer function analysis can provide information in relation 
to the regulation of CBF by cerebral auto-regulation mechanisms, by examining 
the relationship between arterial blood pressure (BP) and CBF fluctuations in 
the frequency domain [9]. The transfer function analysis of BP and cerebral 
NIRS measures has demonstrated that alterations in dynamic cerebral auto-
regulation properties, such as higher coherence or transfer gain, are linked with 
IVH or other mortality risk factors [5-8]. Furthermore, fragile cerebral circulation 
of preterm infants is affected by fluctuations in the systemic circulation 
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associated with the pathophysiology of preterm birth and the first six hours of 
life when complex interactions occur between mechanical ventilation and the 
circulation. In the recent study, the application of DFA was proposed to detect 
early subtle alterations of heart rhythm that could be used to predict impending 
IVH in preterm infants [21]. 
The cerebral autoregulation is an important physiologic mechanism to maintain 
adequate perfusion and oxygenation of the brain and allows concordant 
oscillation of CBF with blood pressure. The use of cerebral perfusion 
measurement to identify preterm infants with high risk of mortality or IVH has 
also been proposed [5-8]. The underlying premise was that impairment of 
cerebral autoregulation could be a potentially important cause of brain injury 
such as IVH. Furthermore, the impairment of cerebral blood flow (CBF) 
controlled by cerebral auto-regulation has been associated with IVH, one 
popular technique for monitoring cerebral circulation in preterm infants is NIRS 
measurements. 
Thus, dynamic monitoring of CBF can be readily used to detect CBF changes 
because of rapid and transient MAP variations [98, 99]. Cerebral autoregulation 
behaves as a high-pass filter [9, 100, 101], which is less effective at higher 
frequency of blood pressure fluctuation. But the static monitoring of CBF using 
xenon-133 clearance techniques [102] or NIRS [103, 104] may fail to detect 
impaired autoregulation because it is a dynamic mechanism. The previous 
finding suggests that autoregulation plays an important role in mediating the 
ultralow-frequency range of MAP variations, because the amplitude of 
spontaneous MAP variations increases when the frequency decreases [105]. 
Similar investigations have demonstrated that the loss of ultralow frequency 
(frequency bands of 0.003–0.020Hz) autoregulation is important in the clinical 
and pathophysiological use [106, 107]. In the previous study, cerebral Doppler 
ultrasound was used to monitor the fast changes of CBF velocity and NIRS 
measurements were utilized to detect changes in cerebral oxygenation which 
reflect fluctuations in CBF. The estimation of the two systems demonstrated that 
increased coherence in the very low frequency range (frequency bands of 
0.020–0.050 Hz) has been an important clinical value [107, 108]. However, 
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cerebral Doppler ultrasound is not so easily applied in clinical settings because 
of special operation. Thus, NIRS is more feasible to the long term measurement 
which is needed to estimate autoregulation in the lower frequency range.  
The cross-spectral analysis between MAP and HbD has also been used in a 
previous study to more specifically identify the impaired autoregulation, which 
was associated with severe cerebrovascular lesions, such as high grade IVH 
and PVL in preterm infants2. However, that study is questionable as the cranial 
ultrasonography was not performed continuously from the first day after birth, 
and thus daily cranial ultrasonography is crucial to identify IVH. 
On the other hand, because the alteration of heart rhythm has been related to 
IVH after its development, thus the techniques used in identifying early subtle 
alterations of heart rhythm could be predictor of impending IVH in preterm 
infants [21]. A recent study explored the potential application of detrended 
fluctuation analysis for identifying early subtle alterations of heart rhythm that 
could be predictive of impending IVH in very low birth weight babies [21]. The 
need for identifying babies with high risk of critical pathological conditions such 
as IVH has also motivated the development of clinical risk and disease severity 
scores for use in the neonatal intensive care setting. 
2.4.2 CRIB II correlation 
A previous study by Wong et al. has suggested that higher CRIB scores in 
preterm infants with high MAP-TOI coherence (in the ultra-low frequency range), 
the existence of a direct correlation has not been examined previously. 
Moreover, previous infant studies only investigated the use of HbD or TOI as a 
surrogate measure of cerebral perfusion [5-8], but it was not clear whether 
HbO2 or HHb could also provide useful information for assessing clinical risk. 
The use of HbO2 to represent cerebral haemodynamics in frequency domain 
analysis has been reported in adult studies [109, 110]. Recently HHb was found 
to not only exhibit high coherence with intracranial pressure (ICP) slow waves 
with good signal-to-noise ratio, but also demonstrate correlated changes with 
the ICP waves during intraventricular infusion [111]. It has therefore been 
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suggested that HHb may be a useful marker of deoxygenated venous blood 
volume. The transfer function analysis of BP and cerebral NIRS measures has 
demonstrated that alterations in dynamic cerebral autoregulation properties, 
such as higher coherence or gain, are linked with IVH or other mortality risk 
factors [5-8].From these investigations, the relationships between CRIB II and 
various spectral measures of arterial baroreflex and cerebral autoregulation 
functions may potentially reflect impairment of arterial baroreflex and cerebral 
autoregulation functions, hence providing further justification for these 
measures as possible markers of clinical risks and predictors of adverse 
outcome.  
2.5 Continuous cardiac monitoring  
Measurement of CO and TRP can provide valuable information for the 
assessment and management of patients needing intensive care, including 
preterm infants in the neonatal intensive care unit (NICU)  [22, 23]. However, 
such measurement requires specialized skill and equipment, and cannot be 
performed continuously. Many extremely low birth weight infants have impaired 
cerebral autoregulation (some with a complete absence of autoregulation) and 
thus a pressure passive cerebral circulation. Intracranial haemorrhage is more 
likely in this state of pressure passive circulation.  Routine methods of 
estimating cardiac function in these preterm infants are dependent on 
echocardiographic estimates of volumetric flow or M-Mode estimates of ejection 
fraction. There are obvious limitations with the need of appropriately trained 
clinicians to perform these examinations and those measurements are valid for 
the short time period of the examination. There is thus an urgent need to 
explore new methods of continuous estimates of cardiac function to support 
clinical decisions to treat hypotension and support vulnerable cerebral 
circulation.     
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2.5.1 Estimation of Cardiac Output  
Cardiac output, which is defined as the volume of blood ejected by the heart per 
unit time, is an important parameters evaluating the overall cardiac status both 
in the seriously ill patients and patients with suspected cardiovascular disease, 
like acute coronary syndromes, hypovolemia, valvular stenosis, myocarditis 
cardiomyopathy and arteriosclerosis [112]. CO is determined by many factors, 
including: cardiac contractility, the nutrient and oxygen requirements of the 
organs and tissues, blood volume status and systemic vascular resistance 
(SVR) [112, 113]. Low CO is a symptom of potential adverse cardiovascular 
conditions such as cardiogenic shock [114]. 
Thermodilution technique is a most common approach in current clinical 
settings and is considered as the gold standard for CO measurement 
[115].However, thermodilution measurement is  an invasive procedure requiring 
the insertion of a pulmonary artery catheter which may involves many risks, 
such as dysrhythmias, pneumothorax and perforation of the heart chamber, 
tamponade and arterial valve damage[116]. With the development of new 
electrical filament wire of the thermodilution catheter, the continuous CO 
monitoring has been proposed in the 1990s to be as accurate as the single 
bolus method [117-119], but its accuracy was questioned during periods of 
hypothermia, such as coming off bypass during cardiac surgery [120, 121]. 
Furthermore, there is significant time delay of readings when a continuous CO 
thermodilution catheter is used. In order to reduce noise and improve reliability, 
the electric filament wire need up to 12 minutes to detect the CO changes. 
Therefore, the catheters should not be used to monitor rapid changes in CO, 
except the trend detection [122]. 
Some alternative methods to estimate CO non-invasively (or with minimal 
invasiveness) has been proposed recently, like Doppler ultrasound, thoracic 
bio-impedance and pulse contour analysis [115, 122, 123], however clinical 
observation still plays a most important role in the clinical decision-making 
process till now. The utilization of non-invasive measurements requires 
specialized skill and equipment, and cannot be performed continuously. As an 
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example, although a series of more portable and dedicated Doppler ultrasound 
probes have been developed to measure blood flow, they still need the skilled 
personnel to operate [124]. On the other hand, the precision of this 
measurement was questioned by the uncertainty of the flow profile and 
diameter of the blood vessel [122], particularly when used in children. Thoracic 
bio-impedance method, which was used to detect the electrical resistance 
changes across the thorax during the cardiac cycle, has been controversial for 
the accuracy and validation in clinical use of critically ill and septic patients [113, 
122].CO measurements can also be derived from the pulse contour analysis by 
continuously monitoring of the arterial pulse pressure waveform from a 
peripheral arterial pulse wave. The area under the pulse wave is related to CO 
and the classic Windkessel model of the circulation was used to convert 
pressure wave to a flow wave [122, 125]. Pulse contour analysis was regarded 
as a minimally invasive method, because central venous and arterial 
cannulations are assumed to already have in a critical care setting. However, it 
is not reliable to monitor the CO trend, since the influence of circulatory 
changes, such as peripheral resistance [122].  
Furthermore, the development of reliable methods for non-invasive estimation 
of CO plays a crucial role in many problems of control of biomedical systems. 
For example, non-invasive control of blood flow has been used to provide long 
term alternative treatment for congestive heart failure patients [126-128]. A 
switching controller has also been proposed to control the drug delivery for 
critically ill patients [129, 130].  
 
2.5.2 Estimation of Total Peripheral Resistance 
Total peripheral resistance (TPR) refers to the resistance to blood flow offered 
by all of the systemic vasculature except the pulmonary vasculature.  TPR is 
primarily determined by variations in blood vessel diameters, which are 
controlled by the sympathetic nervous system through changes of 
vasoconstrictor tone. With the increase of tone, the vessel diameters decrease 
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and the TPR increases. TPR is inversely related to CO and can be calculated 
by MAP/CO. Although TPR can only be calculated from MAP and CO, it is not 
determined by either of these parameters. TPR illustrates the potential 
diagnostic values, as the high TPR may be an indicator of critical illness. For 
example, an increase in TPR may result in ischemic, hemorrhagic shock and 
hemorrhagic stroke [131] , while a depression in TPR may be observed in 
patients with sepsis or anaphylaxis [132].  
2.6 Past techniques used to detect and prevent disease 
Previous studies have suggested that the transfer function analysis of BP and 
cerebral NIRS measures has demonstrated that alterations in dynamic cerebral 
autoregulation properties, such as higher coherence or transfer gain, are linked 
with IVH or other mortality risk factors [5-8]. It has been assumed that the higher 
gain or coherence in the cerebral pressure-flow could reflect impairment of CBF 
control by cerebral autoregulation, thus providing the potential link with brain 
injury such as IVH or other mortality risk factors. The IVH infants had both 
higher TOI and lower FTOE than the non-IVH. The higher level of cerebral 
oxygenation in the IVH cases should not be seen as a positive sign, as it could 
well be a consequence of impaired oxygen extraction capability. In fact, a recent 
study also showed that cerebral oxygenation on the first day of life was higher in 
very preterm infants compared with healthy term infants, with the higher TOI 
again coinciding with lower FTOE in the preterm cases [133]. The reduced 
oxygen extraction was very likely to have an impact on the relationship between 
arterial BP and HHb, as the generation of HHb fluctuation was not only 
dependent on the BP-driven blood flow, but also on the oxygen consumption 
rate in the cerebral capillaries which governed the conversion of HbO2 to HHb.  
Furthermore, cross-spectral analysis was also performed on MAP-RRi to 
provide information about cardiac baroreflex sensitivity [51, 68], and also on 
MAP-HbD and MAP-TOI to provide information about cerebral autoregulation 
[5-8]. In addition, the cross-spectral relationships of MAP-HbO2 and MAP-HHb 
were analysed to reveal the influence of perfusion pressure on the oxygenated 
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and deoxygenated blood volume in the cerebral circulation. The existence of a 
correlation in the Low Frequency band (0.04–0.15 Hz) might relate in part to the 
relatively large contribution of MAP spectral power in this band. The presence of 
large MAP fluctuations could lead to better signal-to-noise ratio for the study of 
cerebral pressure-flow relationship, thus also more reliable detection of cerebral 
autoregulation [134].  A high coherence between arterial BP and NIRS-derived 
surrogate measures of CBF, such as HbD and TOI, has been interpreted as 
signs of a pressure-passive cerebral circulation, with blood flow being highly 
dependent on pressure due to impairment of autoregulation mechanisms [5-8]. 
Previous studies have utilized the DFA to evaluate the fractal dynamics of heart 
rate in various diseases in adult subjects [16, 17]. In a prior study, preterm 
infants who later developed IVH were found to have significantly higher short-
term scaling exponent of heart rate compared with those who did not develop 
IVH [21].Since the altered autonomic control of the heart relates to the 
development of IVH, it is important to detect the difference in fractal dynamics of 
heart rate between these infants with and without IVH. ABP was proposed to be 
applied in the assessment of fractal scaling properties in adult humans based 
on DFA [18-20].Compared with HRV, there are several advantages from 
deriving clinical information using the DFA method. Firstly, this method can be 
performed on an acceptable duration of data (10 min in this case), that is 
practical in the neonatal intensive care setting. Secondly, the information 
(namely the scale exponent) is derived from a specific beat range, which can be 
easily translated to a similar time range or frequency band used in other 
methods such as power spectrum analysis. This would largely facilitate the 
physiological interpretation of the derived parameters. Thirdly, it can be applied 
in conjunction with the commonly used spectral analysis method to provide a 
more complete picture of the underlying cardiovascular dynamics, as both 
methods can provide complementary information [20]. 
There is an urgent need to explore new methods of continuous estimates of 
cardiac function to support clinical decisions to treat hypotension and support 
vulnerable cerebral circulation. Bourgeois et al. performed one of the most 
compelling investigations by using the central ABP waveform analysis 
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technique without the delay of cardiac ejection time. They proposed the arterial 
tree based on the Windkessel model accounting for the lumped compliance of 
the large arteries (AC) and the TPR of the small arteries. Furthermore, 
Windkessel technique proved to be highly accurate, since the diastolic intervals 
of the central ABP waveform indeed decays like pure exponential. However, 
central ABP is seldom measured for monitoring in clinical settings. Routine 
methods of estimating cardiac function in these preterm infants are dependent 
on echocardiographic estimates of volumetric flow or M-Mode estimates of 
ejection fraction. 
2.7 Summary 
IVH is diagnosis of a serious brain damage and might lead to long term 
neurodevelopmental disabilities in preterm infants. The IVH grades was 
classified into 4 grades, from I to IV, which which represent increasingly severe 
stages of the IVH with deteriorated clinical outcomes. If the IVH can be detected 
at the earlier stage, some clinical methods, such as tresuscitation and 
cardiorespiratory management could be used to pretend the low level IVH 
extending to serious stage. Current clinical diagnosis of IVH includes frequency 
spectrum analysis and nonlinear analysis of the corresponding cardiovascular 
time series and NIRS measurements. To assess underlying risk factors of 
mortality and morbidity of preterm infants, the correlation between parameters 
derived from spectral analysis of systemic and cerebral cardiovascular 
variabilities and the CRIB score were established. On the other hand, LVO and 
TPR are two important parameters of the cardiovascular system which can help 
the diagnosis staff to take necessary preventive actions when the patients need 
intensive care.The estimation of LVO and TPR using arterial blood pressure 
waveform analysis has also been briefly reviewed in this chapter. 
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Chapter 3. Frequency spectrum analysis: 
Monitoring Tool for IVH detection and 
adverse outcome in preterm infants 
3.1 Overview  
The mortality and morbidity of the IVH and high possibility of developing long-
term neurodevelopmental disabilities [1, 30] have motivated researchers to 
conduct extensive studies, aiming at better understanding of its pathophysiology 
and development of new diagnostic and treatment techniques. Many extremely 
low birth weight infants suffered from impaired cerebral autoregulation (some 
with a complete absence of autoregulation) and thus a pressure passive 
cerebral circulation.  
This chapter explores the possible ways of using spectral analysis of Near-
infrared spectroscopy (NIRS), blood pressure (BP) and heart rate variability 
(HRV) as a monitoring tool for clinical risk assessment of preterm infants and 
the detection of IVH. Particular interest was also given to quantifying baroreflex 
sensitivity of heart rate (HR) by power spectral and transfer function analysis of 
HRV and BPV [53]. The relationships between CRIB II and various spectral 
measures of arterial baroreflex and cerebral autoregulation functions have 
provided these measures as possible markers of clinical risks and predictors of 
adverse outcome in preterm infants. NIRS for cerebral circulation monitoring 
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has gained popularity in the neonatal intensive care setting, previous study 
have shown that the analysis of NIRS can provide a wide range of features that 
may be useful for tracking cerebral circulation in preterm infants, and thus  the 
possibility of identifying preterm infants with IVH.  
Section 3.2 starts with the development of the spectral analysis algorithm to 
assess the baroreflex sensitivity with HRV and BPV signals, and the cerebral 
autoregulation with NIRS signals. Section 3.3 then explores the potential use of 
the NIRS, BP and HRV for detecting IVH and examined the relationships 
between various spectral measures derived from systemic and cerebral 
cardiovascular variabilities and the CRIB II. The conclusions are drawn in 
Section 3.4. 
3.2 Spectral analysis to find out the relationship with 
CRIB II by Linear regression 
The ability to identify preterm infants with high risk of critical pathological 
conditions at an early stage, such as IVH has motivated the development of 
clinical risk and disease severity scores for use in the neonatal intensive care 
setting. Amongst these scores, the CRIB II has gained wide acceptance as an 
upgrade method of quantifying mortality risk amongst very preterm infants [3].  
As mentioned in Section 2.3.1, impairment of cerebral autoregulation 
mechanism, however, may propose to CBF being more dependent on changes 
in arterial BP, or more “pressure passive”, such that large changes in BP would 
be translated to large CBF fluctuations, hence increasing the risks of 
cerebrovascular injury and brain haemorrhage [5-8]. There is evidence showing 
that cerebral pressure passivity is common in sick preterm infants and may lead 
to IVH and other potentially serious consequences [5].Thus, spectral analysis of 
cerebral perfusion measurement have been utilized to identify preterm infants 
with high risk of mortality or IVH in the previous studies  [5-8]. 
The cross-spectral transfer function analysis is widely used to assess 
alterations in dynamic cerebral autoregulation properties. For example, higher 
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coherence, reduced phase shift and higher gain between arterial BP and CBF 
were regarded as possible indication of impaired autoregulation [9-11].In the 
real clinical setting of preterm infants, the NIRS has been used  for deriving 
surrogate measures of CBF changes, because it can provide simple, non-
invasive and comfortable continuous measurement of CBF. As mentioned in 
Section 2.2.1, the NIRS technique can quantify changes in cerebral oxygenation 
and haemoglobin content, such as the HbO2, HHb and TOI, which reflects 
oxygen saturation in brain vasculature [48]. It has been reported that the TOI 
reflects CBF variations during reduction in perfusion pressure, under the 
conditions of constant arterial oxygen saturation and cerebral oxygen 
consumption [49]. A number of investigators have also proposed that the HbD 
correlated with CBF during hypotensive episodes [5-7, 50]. This log transforms 
technique allows quantification of cerebral pressure passivity as MAP-HbD gain 
in premature infants. The transfer function analysis of BP and cerebral NIRS 
measures has demonstrated that alterations in dynamic cerebral autoregulation 
properties, such as higher coherence or gain, are linked with IVH or other 
mortality risk factors [5-8].  
In this study, we examined how various measures derived from spectral and 
cross-spectral analysis of arterial BP and cerebral NIRS were related to CRIB II, 
an established clinical risk score for preterm infants. Whilst the previous study 
by Wong et al found higher CRIB scores in preterm infants with high MAP-TOI 
coherence (in the ultra-low frequency range), the existence of a direct 
correlation has not been examined previously. Moreover, previous infant studies 
only investigated the use of HbD or TOI as a surrogate measure of cerebral 
perfusion [5-8], but it was not clear whether HbO2 or HHb could also provide 
useful information for assessing clinical risk. The use of HbO2 to represent 
cerebral haemodynamics in frequency domain analysis has been reported in 
adult studies [109, 110]. Recently HHb was found to not only exhibit high 
coherence with intracranial pressure (ICP) slow waves with good signal-to-noise 
ratio, but also demonstrate correlated changes with the ICP waves during 
intraventricular infusion [111]. It has therefore been suggested that HHb may be 
a useful marker of deoxygenated venous blood volume.    
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In addition, we performed cross-spectral transfer function analysis of blood 
pressure variability (BPV) and heart rate variability (HRV) to derive measures 
related to arterial baroreflex modulation of autonomic tone [51, 53, 68]. Analysis 
of BPV and HRV showed a reduced cardiac baroreflex sensitivity (BRS) in adult 
patients with acute intra-cerebral haemorrhage, with BRS being able to predict 
adverse outcomes [69]. Whether BRS was related to clinical risks in preterm 
infants was not known, although a recent study found positive correlation 
between LF BRS gain and postmenstrual age (gestational age + postnatal age) 
[53], suggesting that low BRS in the high risk very preterm infants would be 
likely. The goal of this study was therefore to determine whether measures 
derived from spectral analysis of systemic (HRV and BPV) and cerebral NIRS 
cardiovascular signals were correlated with CRIB, which would help to establish 
these measures as potential indicators of clinical risk in preterm infants.  
 
3.2.1 Methods  
3.2.1.1 Subjects  
This was a prospective clinical investigation, carried out in the neonatal ICU at 
the Nepean Hospital in Sydney, Australia. The study was approved by the 
Sydney West Area Health Service Human Research and Ethics Committee, and 
informed parental consent was obtained in all cases. The cohort comprised 
early low birth weight infants with gestational age <30 wks, without significant 
congenital anomalies who survived at least 2 hours. A single measurement of 
data with 10 min continuous artefact-free segment from each baby was used for 
analysis. Out of the 20 infants with full set of measurements obtained, 17 infants 
had data recordings with sufficiently long artefact-free segment suitable for 
analysis (Data from 3 infants were rejected due to significant artefacts in the 
electrocardiogram or arterial blood pressure recordings). The demographic and 
clinical characteristics of the studied infants are as follows (meanSD): 10 
males 7 females, gestational age 262 wks (range 24-29 wks), birth weight 
1024351 g (range 552-1929 g), CRIB II score 10.32.5, MAP 346 mmHg, 
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RRi 42824 ms, SaO2 954%, TOI 6610%. Out of the 17 infants being studied, 
16 infants were mechanically ventilated, 5 infants suffered from IVH and 1 infant 
died eventually (who did not suffer from IVH).  
 
3.2.1.2 Measurements  
CRIB II score was computed for each infant based on the previously described 
algorithm [27], which incorporates birth weight, gestational age, gender, 
temperature at admission, and base excess. It was scored at the first hour of life.  
Physiological data were collected from the infants within 1-3 hours after birth. 
Electrocardiogram (ECG), arterial BP waveform and arterial blood oxygen 
saturation (SaO2) were acquired via a bedside patient monitor (Philips Agilent 
Systems, Philip Healthcare, North Ryde, Australia). Intra-arterial BP was 
continuously measured via an umbilical or peripheral arterial catheter connected 
to a transducer calibrated to atmospheric barometric pressure and zeroed to the 
midaxillary point. Cerebral near-infrared spectroscopy data were measured by 
the NIRO-300 system (Hamamatsu Photonics, Hamamatsu City, Japan), with 
the sensor probe placed over the skin of the temporoparietal region on the head 
of the infant. The sensor probe of the NIRS-300 monitor consists of a fiber optic 
probe that emits four wavelengths of near-infrared light (775, 825, 850 and 904 
nm), and a receiver probe made of separate aligned photodetectors, which 
permit the measurement of spatially resolved NIRS. The device provides 
measurement of the changes in relative concentration of HbO2 and HHb, and 
also the TOI which is given as the ratio of HbO2 to the total haemoglobin (HbO2 
+ HHb), expressed as a percentage. The NIRS parameters are computed by 
the device every 0.167 s (6 Hz). HbD was calculated as HbO2 – HHb as 
described previously [5-7, 50].  
The ECG, arterial BP, SaO2 and cerebral NIRS signals were simultaneously 
recorded by a data acquisition system (ADInstruments, Sydney, Australia) at a 
sampling rate of 1 kHz. The LabChart software (ADInstruments, Sydney, 
Australia) provided automatic beat-to-beat detection of R-waves from ECG for 
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the computation of R-R interval (RRi) and heart rate (HR), and also the 
computation of mean arterial pressure (MAP) from the arterial BP waveform. 
3.2.1.3 Signal processing  
Analysis was performed on uninterrupted data recordings of 10 minutes 
(obtained within 1-3 hours after birth from each infant) without noticeable 
corruption by artefacts.  All signal processing was implemented in Matlab 
(Natick, MA, USA). Spikes in beat-to-beat time series of RRi due to occurrence 
of abnormal pulse intervals (e.g. prolonged heart period resulting from a missed 
heart beat), which constituted less than 3% of the total number of beats, were 
removed and replaced by linear interpolation of the beat values immediately 
preceding and following the replaced beats.  
Movement artifact is a common problem in the biomedical signal processing, 
because biomedical sensors are sensitive to subject movement and can cause 
high amplitude short-time perfusions in the signals. These problems will bring 
the noises especially in the second-order statistics such as spectral analysis 
and correlation[135]. In heart rate series, for instance, the fluctuations in the 
normal sinus rhythm of the beat-to-beat interval are much lower than the 
movement artefact, and thus the HRV will be seriously distorted, especially in 
the power spectral density.  
In this study, an automated method to reject noise spikes (ectopics or artifacts) 
for the long data set (≥10 mins) of RR interval was needed. In the real collected 
data, the incidence of artifact is rare and the amplitude of the artifact is very 
high, it has been suggested that impulsive artifact is more accurately modelled 
as a white noise process. Although it is highly possible that there is no noise at 
all, the high amplitude of noise will dramatically increase the mean value of the 
signal. Thus, the fixed threshold filters will not be suitable in the noise rejection 
of HRV. An impulse rejection filter for artefact removal in spectral analysis of 
HRV has been proposed by J. McNames [135] without the  arbitrary threshold. 
It considers deviation from 5 points moving median filter and used an arbitrary 
threshold factor (1.483) to calculate the following test statistic D (n): 
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                                                                                (3.1) 
where    { } means the median operation over the entire signal and   is the 
median value of the entire signal, thus,   = med{x(n)}. The denominator is a 
robust evaluation of the standard deviation of an equivalent Gaussian signal. 
For the long records, the median operation is replaced by moving window 
because of the non-stationary behaviour. The filtered signal was defined as  
 ̂    and then was calculated as follows: 
 ̂    {
           
   ̂                           
                                                                    (3.2) 
where   is a user-specified threshold and   ̂   is an interpolated value of the 
signal at the time point n. A median filter was used to calculate the interpolation 
value as follows: 
  ̂       {       | |  
    
 
}                                                               (3.3) 
where   is the window length of the segment centered about point n. Based on 
the comparison of filter results in different value of threshold and window length, 
the threshold of 4 and a window length of 5 sample points are selected in the 
final  filter. As shown in the middle of Figure 3-1, it appears that most of the 
noise spikes can be removed with the threshold after the proper window length 
was selected. The noise spikes can be sufficiently deleted shown in the bottom 
of Figure 3-1.   
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Figure 3-1: The results of impulse rejection filter in RRi.   
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3.2.1.4 Frequency spectrum analysis 
 
The RRi and MAP time series were converted to evenly spaced samples at 8 
Hz using a previously proposed method to obtain the HRV and BPV signals 
[136]. The HbO2, HHb and TOI signals were also resampled to 8 Hz, by 
performing moving averaging (0.25 s window) with a sampling interval of 0.125 
s. Linear detrending was performed on the resampled signals prior to spectral 
analysis. The power spectral density (PSD) of each signal was computed by the 
Welch method – this involved dividing each of the 10 min segments into smaller 
sections of 4 min with 75% overlap, multiplying each section with a Hanning 
window, performing a 2048-pt fast Fourier transform (FFT) then squaring the 
magnitude to give the auto power spectrum, and finally averaging the power 
spectra of all segments to obtain the PSD of the signal.  
The Welch method was also used, which involved averaging the cross power 
spectra from multiple sub-segments in a similar fashion as the computation of 
PSD described earlier. With the auto power spectra of signals x and y defined 
as Pxx(f) and Pyy(f) respectively (f represents frequency) and the cross power 
spectrum of x-y as Pxy(f), the transfer function of x-y (from x to y) was computed 
as follows: 
     
      
      
                                                                                                  (3.4) 
and the magnitude and phase angle of the transfer function could be obtained 
accordingly. The magnitude-squared coherence function was defined as follows: 
          
|      | 
            
                                                                                      (3.5) 
The coherence assesses the linear correlation between spectral components in 
the two signals, with a value ranging from 0 (lack of linear correlation) to 1 
(perfect linear relationship). Cross-spectral analysis was performed on MAP-
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HbO2, MAP-HHb, MAP-HbD and MAP-TOI using the Welch method to provide 
information about cerebral autoregulation [5-8]. 
In this study, we have performed correlation analysis over a large number of 
parameters, including information from 3 different frequency bands and a 
number of NIRS measures. We believe this was necessarily given that each 
frequency band and each NIRS measure might carry different physiological 
meanings, and presenting all the information together would provide a more 
complete picture to the readers. For example, in the study of HRV and BPV, 
different frequency bands have been attributed to specific physiological 
mechanisms, and similar argument may apply to the study of cerebral 
autoregulation (although the precise mechanisms remain to be fully understood). 
The NIRS measures are also not equivalent, for example HbO2 and HHb 
represent oxygenated and deoxygenated blood respectively, whose response to 
MAP perturbation would be different dependent on the tissue metabolic status 
(a key factor of autoregulation). The value of analysing multiple bands and 
NIRS measures was highlighted by the fact that TOI VLF percentage power and 
MAP-HHb LF coherence (two different measures in different bands) both 
exhibited correlation with CRIB, with TOI VLF percentage power also reflecting 
similar information as the baroreflex sensitivity measure.  
Since we have chosen to perform correlation analysis on all the NIRS measures 
(HbO2, HHb, HbD and TOI) in all frequency bands a priori, and that each 
measure and each band is considered different from each other, we did not 
apply post-hoc correction for multiple tests. However with transfer function 
analysis of baroreflex, we have removed SBP-RRi and only reported MAP-RRi 
given the similarity of meaning conveyed by the two measures, and also to be 
consistent with the cerebral autoregulation analysis that used MAP. 
The cardiovascular variability spectra of the infants were divided into three 
bands, based on those described previously [5, 8, 53]: the very low frequency 
band (VLF, 0.02–0.04 Hz), the low frequency band (LF, 0.04–0.15 Hz) and the 
mid frequency band (MF, 0.15–0.25 Hz). The current definition of LF band is the 
same as that widely used in human adult studies, considered to be under the 
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influences of the autonomic nervous system (sympathetic and vagal nerve 
activities) and vasomotor regulation mechanisms [51]. A previous infant study 
has used this band to quantify baroreflex sensitivity via transfer function 
analysis of BPV and HRV [53]. In another study, a wider frequency range (0.05–
0.25 Hz) was used as the LF band in the study of cerebral autoregulation based 
on transfer function analysis of MAP and HbD [5]. This expanded range 
includes the “gap” (0.15-0.25 Hz) between the conventional LF band and the 
breathing frequency of infants (> 0.25 Hz), which has been assigned as the MF 
band in the current study. The spectral band below 0.04 Hz is typically 
considered as the VLF band, whose meaning is not totally clear although the 
influence of local autoregulation mechanism has been implicated [51, 111]. The 
current definition of VLF band is 0.02-0.04 Hz, similar to that adopted in a 
previous infant study (0.02-0.05 Hz) for the study of cerebral autoregulation 
based on transfer function analysis of MAP and TOI [8]. Other studies of 
cerebral autoregulation in infants also examined the very slow trend at < 0.02 
Hz, termed the ultra-low frequency (ULF) band [6-8], although this would not be 
included in the current analysis given the difficulty in deriving reliable estimate 
of this band based on a relatively short segment of 10 min.  
The relative and percentage powers reflect the relative contribution of different 
oscillations in the signals, and can help to reduce the large inter-subject 
variability in the spectral powers that hinders comparison. In the presentation of 
relative powers, we have made no assumption regarding underlying relationship 
between oscillations in different bands (e.g. when %LF increases, it merely 
means that the percentage contribution of LF power in the total power has 
increased). We have found significant relationships with CRIB for spectral 
powers expressed in relative terms but not in absolute terms, which reinforced 
the idea that the relative spectral powers carried important information not 
apparent from the absolute powers. 
Within each band, the spectral power was obtained by integrating the power 
spectrum over the given frequency range. The percentage power (%VLF, %LF 
and %MF) was computed by dividing the power in each band by the sum of the 
three bands, expressed as percentage. The normalised mid frequency power 
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(nMF) was also obtained by dividing the MF power by the sum of LF and MF 
powers. The transfer function parameters (gain, phase and coherence) in each 
band were computed by averaging values at frequencies with coherence  0.5, 
or from the frequency with the maximum coherence if coherence < 0.5, as this 
represented the frequency at which the signals were most strongly correlated 
[68, 137]. The proportion of shared variance in both signals would be at least 50% 
at coherence  0.5. In addition, the average coherence of the whole band was 
computed by averaging all values within each band. 
 
3.2.1.5 The coherence spectrum analysis for more than two signals 
The coherence spectrum was used in the section 3.2.1.4 to measure of the 
linear statistical relationship between two time series, however the coherence 
spectrum analysis for more than two signals has never been studied. Recently, 
a method to include more than two processes in the coherence spectrum 
analysis haw been proposed by David et al. [138] .  
In the coherence analysis between two signals, the magnitude squared 
coherence spectrum (MSC) was often used to provide a frequency-dependent 
measure of the linear relationship between two stationary random processes. 
However, when more than two signals are involved in the calculation of MSC, it 
is not practical to measure all of the pairwise MCS between these signals. In 
order to include more signals in the coherence analysis, the generalized 
magnitude squared coherence (GMSC) spectrum is defined as a function of the 
largest eigenvalue of a matrix including all the complex coherence spectra. The 
value changes from zero to one, which attains its maximum when the signals 
are perfectly related with each other and provide a tool for us to quantify the 
contribution of each signal to the overall correlation. 
The M ≥2 signals are  [ ],…,   [ ], the complex coherence spectrum between 
the i-th and j-th signals are defined as follows: 
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√                
   ,                     i , j =1, 2 , 3                                   (3.6) 
Where          is the cross-spectrum and      is the power spectral density of 
the i-th signal. In order to extend the method to general case (M ≥2), a matrix is 
defined as follows, which contains all pairwise complex coherence spectra: 
∑      
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                  ]
 
 
 
 
                                                (3.7)         
 
which can be rewritten as follows: 
∑       
    
           
    
                                                                     (3.8) 
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[
 
 
 
 
                         
                         
   
                         ]
 
 
 
 
                                               (3.9) 
and        is a diagonal matrix whose entries are[     ]            . 
Then, the GMSC is defined as   , where 
      
 
 
      ∑                                                                                 (3.10) 
Here w is each frequency point and      ∑       is the largest eigenvalue of 
the matrix ∑     .Then we could get the matrix at every sampling point and 
calculate the maximal eigenvalue of each matrix to calculate the GMSC. The 
GMSC spectrum is maximum when the M time series are perfectly pairwise 
correlated at that frequency point, and minimum when all the signals are 
uncorrelated. 
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Based on the linear regression results from section 3.2.1.4 , three to four 
signals were selected to do the three to four coherence spectrum analysis. For 
M=3, the matrix is simplified as follows: 
∑      [
                 
                 
                 
]                                                    (3.11) 
     
 
 
      ∑                                                                                 (3.12) 
 
It was hypothesized in this study that the GMSC of three or four signals will 
increase the value of coherence of the related signals found in the coherence 
analysis in two signals. 
 
3.2.1.6 Data analysis 
The results for the cohort were presented as mean ± SD. Least-squares linear 
regression analysis was carried out between CRIB II score and each of the 
physiological/spectral parameters. The Pearson’s correlation coefficient (r) was 
computed, and the relationship between two variables was considered 
significant if P < 0.05. In addition, regression analysis was performed between 
the gestational age and each of the parameters. For a particular type of 
variables (spectral power, transfer gain, coherence or phase) whose majority of 
parameters (>50%) did not follow normal distribution (based on the 
Kolmogorov-Smirnov test), logarithmic transformation would be performed to 
provide normally distributed parameters, prior to performing regression analysis.  
We applied transformation on a class of variable rather than on individual 
variables, to avoid inconsistency in the data being presented and to facilitate 
comparison of variables within the same class. Based on the normality test, 
transformation was performed on the absolute spectral power and transfer gain 
parameters. 
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3.2.2 Results  
The values of the spectral powers and transfer function parameters for the 
cohort are summarised Table 3-1 and Table 3-2 respectively, and the 
correlations between CRIB II score and various parameters are shown in Table 
3-3. Logarithmic transformation was performed on the absolute spectral powers 
and transfer gains to provide normally distributed parameters, prior to 
performing regression analysis. A number of significant and moderate 
correlations were identified; with respect to the percentage/normalised powers, 
positive correlations with CRIB II were found in MAP nMF (r = 0.61, P = 0.009), 
MAP %MF (r = 0.56, P = 0.02), and TOI %VLF (r = 0.55, P = 0.023). The 
transfer function gain (after logarithmic transformation) of MAP-RRi in the LF 
band, which represents cardiac BRS, was inversely related to CRIB II (r = -0.61, 
P = 0.01).  
Analysis of percentage and normalised powers from MAP and TOI frequency 
spectra also revealed interesting correlations with CRIB II. Relative dominance 
of VLF fluctuations in TOI (as illustrated in Figure 3-5) was associated with 
higher CRIB II score, and quite a strong negative correlation was seen between 
TOI %VLF and gestation age (r = -0.75, P = 0.0005). The suppression of LF 
and MF powers would be the main reason for this relative dominance of VLF 
band, given that the absolute powers in these two bands had weak (but non-
significant) negative correlation with CRIB (Table 3-3). A possibility existed that 
the lower BRS (with lower gestational age) might relate to the suppression of LF 
and MF powers in TOI, given the potential link between baroreflex and cerebral 
autoregulation mechanisms [139]. As shown in the scatter plots (Figure 3-2), it 
was clear that the 5 infants with the highest CRIB scores of 12-15 all had low 
BRS and high TOI %VLF, suggesting possible connection between the two 
mechanisms. It was noteworthy that significant relationships with CRIB were 
found when spectral powers were expressed in relative terms, but not in 
absolute terms, which reinforced the idea that the relative spectral powers 
carried important information not apparent from the absolute spectral powers.  
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Table 3-1: Spectral powers of systemic and cerebral cardiovascular signals in 
the cohort of preterm infants.  
  VLF LF MF 
RRi Power (ms2) 4787 69120 1422 
 % power 3317 4710                                  2013 
 nMF    2715 
MAP Power (mmHg2) 0.130.09 0.220.18 0.060.05 
 % power 3512 5310 134 
 nMF   196 
HbO2 Power ((mol/L)
2) 0.0470.042 0.0740.082 0.0200.050 
 % power 4519 4715 810 
HHb Power ((mol/L)
2) 0.0210.037 0.0510.120 0.0280.092 
 % power 4119 4713 1213 
HbD Power ((mol/L)
2)  0.0430.026 0.0470.039 0.0140.024 
 % power 5022 4015 912 
TOI Power (%2) 0.110.19 0.290.46 0.190.35 
 % power 2612 507 2412 
Values are mean  SD. VLF, very low frequency (0.02-0.04 Hz); LF, low 
frequency (0.04-0.15 Hz); MF, mid frequency (0.15-0.25 Hz); RRi, R-R interval; 
MAP, mean arterial pressure; HbO2, oxygenated haemoglobin; HHb, 
deoxygenated haemoglobin; HbD, haemoglobin difference; TOI, tissue 
oxygenation index; % power, the band power divided by sum of powers in all 
three bands; nMF, normalised mid-frequency power computed from 
MF/(LF+MF).   
49 
 
 
Table 3-2: Transfer function analysis of systemic and cerebral cardiovascular 
signals in the cohort of preterm infants.  
  VLF     LF    MF 
MAP-RRi Gain (ms/mmHg) 10.914.4 11.611.3 13.214.9 
 Coherence 0.560.13 0.610.06 0.600.06 
 Phase (rad) 0.162.07 -0.461.32 0.051.45 
MAP-HbO2 Gain (mol/L/mmHg) 0.440.17 0.410.28 0.360.31 
 Coherence 0.580.15 0.670.06 0.670.08 
 Phase (rad) 0.211.69 -0.650.94 -0.900.98 
MAP-HHb Gain (mol/L/mmHg) 0.220.13 0.270.31 0.320.41 
 Coherence 0.570.16 0.650.05 0.620.06 
 Phase (rad) -0.351.86 0.080.88 -0.371.17 
MAP-HbD Gain (mol/L/mmHg) 0.430.18 0.340.21 0.360.35 
 Coherence 0.590.16 0.650.08 0.640.06 
 Phase (rad) -0.091.52 -0.770.81 -0.980.95 
MAP-TOI Gain (%/mmHg) 0.560.42 0.940.89 1.391.45 
 Coherence 0.560.10 0.620.04 0.600.04 
 Phase (rad) -0.501.66 -0.600.79 -0.121.25 
Values are mean  SD. VLF, very low frequency (0.02-0.04 Hz); LF, low 
frequency (0.04-0.15 Hz); MF, mid frequency (0.15-0.25 Hz); RRi, R-R interval; 
MAP, mean arterial pressure; HbO2, oxygenated haemoglobin; HHb, 
deoxygenated haemoglobin; HbD, haemoglobin difference; TOI, tissue 
oxygenation index. Gain, phase and coherence are derived from cross-spectral 
transfer function analysis of the given pair of signals.   
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Table 3-3: Correlations between CRIB II and spectral powers of systemic and 
cerebral cardiovascular signals in the cohort of preterm infants.  
  VLF  LF  MF  
  r P r P r P 
RRi Power -0.33 0.20 -0.38 0.13 -0.37 0.14 
 % power 0.08 0.77 -0.27 0.30 0.11 0.68 
 nMF     0.11 0.68 
MAP Power 0.08 0.76 0.16 0.54 0.43 0.08 
 % power -0.17 0.52 -0.05 0.86 0.56 0.020* 
 nMF     0.61 0.009* 
HbO2 Power -0.06 0.81 -0.09 0.73 -0.22 0.40 
 % power 0.13 0.62 -0.03 0.91 -0.21 0.42 
HHb Power -0.08 0.75 -0.21 0.42 -0.23 0.38 
 % power 0.35 0.17 -0.30 0.24 -0.22 0.40 
HbD Power 0.15 0.57 -0.11 0.69 -0.28 0.28 
 % power 0.31 0.23 -0.21 0.43 -0.30 0.25 
TOI Power -0.09 0.73 -0.25 0.34 -0.33 0.19 
 % power 0.55 0.023* -0.20 0.45 -0.44 0.076 
Correlation coefficients and p-values (r and P) from linear regression against 
CRIB II were presented. Logarithmic transformation was performed on the 
spectral power values prior to regression analysis.  VLF, very low frequency 
(0.02-0.04 Hz); LF, low frequency (0.04-0.15 Hz); MF, mid frequency (0.15-0.25 
Hz); RRi, R-R interval; MAP, mean arterial pressure; HbO2, oxygenated 
haemoglobin; HHb, deoxygenated haemoglobin; HbD, haemoglobin difference; 
TOI, tissue oxygenation index; % power, the band power divided by sum of 
powers in all three bands; nMF, normalised mid-frequency power computed 
from MF/(LF+MF). *P < 0.05.   
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With respect to the cerebral autoregulation parameters, MAP-HHb LF 
coherence was positively related to CRIB II with the highest correlation overall (r 
= 0.64, P = 0.006). MAP-HbO2 MF phase also had an inverse relationship (r = -
0.58, P = 0.014), although examination of the regression plot showed that this 
relationship was mainly driven by one subject who had much higher phase and 
lower CRIB II compared with the rest of the group. The regression plots of the 
important relationships found are shown in Figure 3-2. 
Further analysis showed correlations of gestational age with MAP-RRi LF gain 
(BRS) (r = 0.70, P = 0.002 after logarithmic transformation of the gain) and 
TOI %VLF (r = -0.75, P = 0.0005), with values higher than those between CRIB 
II and the parameters. Other parameters, however, had lower correlations with 
gestational age compared with CRIB II: MAP nMF (r = -0.42, P = 0.09), MAP-
HHb LF coherence (r = -0.60, P = 0.01) and MAP-HbO2 MF phase (r = 0.47, P 
= 0.06). 
Figure 3-3 a-b shows the signal traces from two representative infants who had 
low/high CRIB II scores (5 and 14 respectively) along with low/high MAP-HHb 
LF coherences. Note the presence of similar low frequency oscillations (~6-10 s) 
in MAP and HHb in the high CRIB score case, in contrast with the dissimilar 
fluctuations in the low CRIB score case. The corresponding MAP-HHb 
coherence plots of these infants are shown in Figure 3-4, which illustrate the 
high LF coherence (close to 1 at 0.14 Hz) in the high CRIB score case. The TOI 
variability and its frequency spectrum for these two infants are displayed in 
Figure 3-5. The presence of oscillations in the LF and MF range was noted in 
the low CRIB score case, in contrast with the lack of oscillations in the high 
CRIB score case, with the subject having high %VLF due to the relative 
dominance of VLF over LF and MF fluctuations. The MAP variability spectrum 
of the low CRIB score infant is also shown in Figure 3-6a, along with an infant 
with relatively high CRIB score of 11 and high MAP nMF in Figure 3-6b. Note 
the occurrence of sharp MAP transients that introduce MF power in the 
frequency spectrum, contributing to the high nMF.   
52 
 
 
Table 3-4: Coherence analysis of systemic and cerebral cardiovascular signals 
in the cohort of preterm infants.  
          VLF         LF   MF 
MAP-RRi Coherence 0.56 0.61 0.60 
MAP-HbO2 Coherence 0.58 0.67 0.67 
MAP-HHb Coherence 0.57 0.65 0.62 
MAP-HbD Coherence 0.59 0.65 0.64 
MAP-TOI Coherence 0.56 0.62 0.60 
RRi-HbD-MAP Coherence 0.29 0.30 0.34 
RRi-HbO2-MAP Coherence 0.41 0.48 0.09 
RRi-TOI-MAP Coherence 0.33 0.27 0.15 
RRi-MAP-HbD-HbO2 Coherence 0.27 0.30 0.38        
Values are mean VLF, very low frequency (0.02-0.04 Hz); LF, low frequency 
(0.04-0.15 Hz); MF, mid frequency (0.15-0.25 Hz); RRi, R-R interval; MAP, 
mean arterial pressure; HbO2, oxygenated haemoglobin; HHb, deoxygenated 
haemoglobin; HbD, haemoglobin difference; TOI, tissue oxygenation index. 
Gain, phase and coherence are derived from cross-spectral transfer function 
analysis of the given pair of signals. 
For the coherence spectrum analysis multiple signals (3 or 4 signals), the 
results are summarised in Table 3-4: Coherence analysis of systemic and 
cerebral cardiovascular signals in the cohort of preterm infants.Table 3-4.The 
53 
 
GMSC of 3 to 4 signals did not show higher than the coherence of two signals. 
While our results were seemingly at odd that the GMSC of RRi-HbO2-MAP in 
MF band is only 0.09, as the coherence of HbO2-MAP and MAP-RRI both have 
quite high correlation in MF band. Future studies should examine the longer 
recordings with multiple measurements to improve the reliability of multiple 
coherence analysis. 
3.2.3 Discussion 
This study addressed the relationship between CRIB II, an established clinical 
risk score for preterm infants [27], and various measures derived from spectral 
analysis of systemic and cerebral cardiovascular variability, which were 
previously found to be linked with brain haemorrhage (IVH) or other mortality 
risk factors [5-8]. Significant moderate correlations were found between CRIB II 
and spectral measures that potentially reflect impairment of arterial baroreflex 
and cerebral autoregulation functions, hence providing further justification for 
these measures as possible markers of clinical risks and predictors of adverse 
outcome.  
The MAP-HHb LF coherence, which presumably reflects the level of cerebral 
autoregulation, was positively related to CRIB II, with the highest overall 
correlation (r = 0.64, P = 0.006). The existence of a correlation in the LF band 
but not the VLF or MF band might relate in part to the relatively large 
contribution of MAP spectral power in this band (as shown in Figure 3-2). The 
presence of large MAP fluctuations could lead to better signal-to-noise ratio for 
the study of cerebral pressure-flow relationship, thus also more reliable 
detection of cerebral autoregulation [134].  A high coherence between arterial 
BP and NIRS-derived surrogate measures of CBF, such as HbD and TOI, has 
been interpreted as signs of a pressure-passive cerebral circulation, with blood 
flow being highly dependent on pressure due to impairment of autoregulation 
mechanisms [5-8]. The study of MAP-HHb coherence, however, has not been 
reported previously. The fact that highest correlation was obtained from MAP-
HHb coherence would suggest that this relationship might hold important clinical 
value, thus should not be neglected. As shown in Figure 3-3 B, it appears that 
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MAP-synchronised LF oscillations are more apparent in HHb compared with 
HbO2 in the high CRIB score infant.  As the oxygen-carrying arterial blood 
travels through the capillary compartment in the cerebral microvasculature, the 
oxygen consumption by the brain tissue metabolism would convert oxygenated 
haemoglobin HbO2 into deoxygenated haemoglobin HHb, that subsequently 
enters the venous blood. The high MAP-HHb LF coherence might suggest the 
lack of vascular control by cerebral autoregulation mechanisms operating in the 
LF range [9], such that arterial pressure change was able to directly drive blood 
flow through a cerebral microvascular network that consumed oxygen and 
facilitated the conversion of HbO2 to HHb. The physiological significance of the 
MAP-HHb relationship and its implication on cerebral autoregulation warrants 
further investigations in future.   
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Figure 3-2: Linear regression analysis of spectral measures derived from mean 
arterial pressure (MAP), heart period (RRi) and cerebral near infrared 
spectroscopy (NIRS) versus Clinical Risk Index for Babies (CRIB II): (a) Top 
left: low frequency coherence of MAP and deoxygenated haemoglobin (HHb); 
(b) Top right: low frequency transfer gain of MAP and RRi (after logarithmic 
transformation); (c) Bottom left: very low frequency percentage power of tissue 
oxygenation index (TOI); (d) Bottom right; MAP normalised mid-frequency 
power. 
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Figure 3-3: Snapshots of mean arterial pressure (MAP) and cerebral 
oxygenated and deoxygenated haemoglobin (HbO2 and HHb) in one infant with 
a low CRIB II score of 5 (panel A) and another infant with a high CRIB II score 
of 14 (panel B). The HbO2 and HHb signals shown represent changes in 
concentration rather than the absolute values. Note the presence of similar low 
frequency oscillations (~6-10 s) between MAP and HHb in the high CRIB score 
case (panel B) who had high MAP-HHb coherence (Figure 3-4, bottom), in 
contrast with the dissimilar fluctuations in the low CRIB score case (upper panel) 
who had lower coherence (Figure 3-4, top).   
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Figure 3-4: Cross-spectral coherence of mean arterial pressure (MAP) and 
cerebral deoxygenated haemoglobins (HHb) of one infant (top) with a low CRIB 
II score of 5 and relatively low coherence in the low frequency range (LF, 0.04-
0.15 Hz), and another infant (bottom) with a high CRIB II score of 14 and high 
LF coherence (close to 1 at 0.14 Hz). MAP and HHb show similar LF 
oscillations in the high coherence case and dissimilar fluctuations in the low 
coherence case, as illustrated in Figure 3-3.    
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Figure 3-5: Snapshots of tissue oxygenation index (TOI) variability and its 
frequency spectrum in one infant with a low CRIB II score of 5 (panel A) and 
another infant with a high CRIB II score of 14 (panel B). TOI traces were 
lowpass filtered to <0.25 Hz to highlight the fluctuations being analysed. Note 
presence of low frequency (LF) and mid frequency (MF) oscillations in the low 
CRIB score case, in contrast with the lack of oscillations in the high CRIB score 
case. This subject also had a comparatively high VLF percentage power 
(%VLF, in 0.02-0.04 Hz).  
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Figure 3-6: Snapshot of mean arterial pressure (MAP) variability and its 
frequency spectrum in one infant with low CRIB II score of 5 (panel A) and 
another infant with relatively high CRIB II score of 11 (panel B). MAP traces 
were lowpass filtered to <0.25 Hz to highlight the fluctuations being analysed. 
Note presence of somewhat periodic sharp MAP transients (panel B) that 
introduce spectral powers in the mid frequency range (0.15-0.25 Hz), leading to 
high normalised MF power in the high CRIB score case.  
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Cardiac baroreflex sensitivity, measured by transfer function gain of BPV and 
HRV in the LF range, was inversely related to CRIB II. The negative phase (BP 
leading RRi) and >0.5 coherence in this band justified the possible existence of 
a baroreflex-driven relationship [68]. The correlation of BRS and CRIB II was 
believed to be partly due to the relationship between BRS and gestational age (r 
= 0.70, P = 0.002 after logarithmic transformation), a major component of the 
CRIB II score [27]. Previous studies of human infants showed strong positive 
correlation (r = 0.80) between postmenstrual age (gestational age + postnatal 
age) and BRS (from LF transfer gain), suggesting a progressive maturation of 
baroreflex vagal function with age [53], which may explain the positive 
relationship between BRS and gestational age observed in our study. From 
Figure 3-2b, it seems clear that infants with relatively high CRIB II (> 10) all had 
low BRS, whilst those with lower CRIB II displayed a wide range of BRS. The 
depressed BRS may contribute to increased clinical risks, as the study of adult 
patients showed a reduced cardiac BRS with acute intra-cerebral haemorrhage, 
with BRS being able to predict adverse outcomes [69]. 
Dominance of MF over LF fluctuations in MAP was related to a higher CRIB II 
score. The physiological significance of the MF band in infants has not been 
addressed previously; in our study, this band (0.15-0.25 Hz) was defined as the 
“gap” between the respiration frequency of infants (> 0.25 Hz) and the 
conventional LF band (0.04-0.15 Hz) that was typically adopted in human adult 
studies. Observations of our infant data showed that the relative increase in MF 
power seemed to arise from sharp MAP transients, which introduced relatively 
high frequency spectral components at the MF range (Figure 3-6b). The 
presence of these BP transients might relate to the lack of compensation by the 
immature baroreflex mechanism, as in the case of normal adults, the baroreflex 
should be capable of dampening the BP change by adjustment of heart rate 
and/or peripheral vascular resistance. 
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3.2.4 Limitations 
The rationale of this study was to establish the link between parameters derived 
from spectral analysis of systemic and cerebral cardiovascular variabilities and 
clinical risk of preterm infants, via examining the correlation of these parameters 
with the CRIB score. The existence of a correlation would provide justification 
that these parameters reflect underlying risk factors in the preterm infants, with 
potential pathophysiological meaning. The intention, however, was not to derive 
an estimate of CRIB score using the spectral measures, given that it could be 
readily computed based on available clinical data at the first hour of life, 
including birth weight, gestational age, gender, temperature on admission and 
blood base excess. Nevertheless it should be noted that CRIB score is a static 
and one-off measure, while information from spectral analysis of cardiovascular 
signals can be continuously acquired to monitor the conditions of infants in real 
time. Although this potential benefit could not be demonstrated by the current 
study, it should be explored in future via better study design.  
There were several limitations to the current investigation. Firstly, only a 
relatively short segment of continuous and artefact-free data was obtainable 
from the current subject cohort. The 10 min data length permits reliable 
extraction of spectral parameters down to the VLF range. For the study of the 
ultra-low frequency range (< 0.02 Hz), which was found to be associated with 
clinical risks in previous infant studies [6-8], a longer data segment will be more 
appropriate. Secondly, only a single data segment was used from each subject 
in the analysis. It has been suggested that long recordings with multiple 
measurements can improve reliability of coherence analysis for assessing 
cerebral autoregulation in infants [134]. Future studies should examine the 
stability of the various spectral measures over time, to determine whether they 
provide satisfactory precision that permits discrimination between the infants. 
Thirdly, the sample size was not very large, and a larger sample size will be 
desirable from the statistical perspectives.  
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3.2.5 Summary  
In this study, we examined the relationships between various spectral measures 
derived from systemic and cerebral cardiovascular variabilities, and CRIB II, an 
established clinical risk score for preterm infants in the neonatal intensive care 
setting. Significant and moderate correlations with CRIB II were identified from a 
number of parameters including MAP nMF, TOI %VLF, MAP-RRi LF gain and 
MAP-HHb LF coherence. The relationships between CRIB II and various 
spectral measures of arterial baroreflex and cerebral autoregulation functions 
have provided further justification for these measures as possible markers of 
clinical risks and predictors of adverse outcome in preterm infants. 
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3.3 Transfer function analysis to identify infants with 
and without IVH   
In the previous section, we utilized the spectral analysis to examine the 
relationships between various spectral measures derived from systemic and 
cerebral cardiovascular variabilities and the CRIB II. Similarly the spectral 
analysis of NIRS can also be used to identify infants with IVH. Previous studies 
have reported that the transfer function analysis of BP and cerebral NIRS 
measures has demonstrated that alterations in dynamic cerebral autoregulation 
properties, such as higher coherence or transfer gain, are linked with IVH or 
other mortality risk factors [5-8]. It has been suggested that the higher gain or 
coherence in the cerebral pressure-flow relationship could reflect impairment of 
CBF control by cerebral autoregulation, thus potentially linked with brain injury 
such as IVH. 
In this study, we examined whether the various parameters derived from cross-
spectral transfer function analysis of arterial BP and cerebral NIRS, including 
gain, phase and coherence, could demonstrate significant difference between 
preterm infants with and without IVH. In contrast to previous studies which 
adopted a single NIRS measure (TOI or HbD) as a surrogate of CBF, we 
examined the transfer function relationships of arterial BP to a number of NIRS 
measures including HbO2, HHb, HbD and TOI, to understand which of the 
measures might be more useful for the detection of IVH. In addition, we also 
compared the mean values of the NIRS-derived TOI and FTOE between the 
two groups of infants. 
The data and spectral analysis was performed using the same procedure as 
mentioned in section 3.2.1. Clinical characteristics of included patients are the 
same as as mentioned in section 3.2.2.Out of the 17 infants, 16 infants were 
mechanically ventilated, 5 infants suffered from IVH and 1 infant died eventually. 
The results for the IVH and non-IVH infants were presented as mean ± SEM. 
Logarithmic transformation was performed on the transfer gain parameters as 
they do not follow a normal distribution.  Differences between two groups were 
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compared with the Student’s t test. A P value of <0.05 was considered 
significant. 
3.3.1 Results 
The mean values of the physiological variables are shown in Table 3-3,Table 
3-5. TOI was significantly higher and FTOE was significantly lower in the IVH 
infants compared with the non-IVH infants (P value = 0.011 and 0.015 
respectively).  
 
Table 3-5: Physiological variables in the cohort of preterm infants  
 IVH Non-IVH P  Value  
RRi (ms) 441±11 423±6 0.160  
SBP (mmHg) 44±5 43±2 0.760  
MAP (mmHg) 33±3 35±1 0.695  
TOI (%) 76±5 63±2 0.011*  
SaO2 (%) 95±5 95±1 0.863  
FTOE (%) 20±6 34±2 0.015*  
Values are mean ± SEM. IVH, intraventricular hemorrhage; RRi, R-R interval; 
SBP, systolic blood pressure; MAP, mean arterial pressure; TOI, tissue 
oxygenation index; SaO2, arterial oxygen saturation; FTOE, fractional tissue 
oxygen extraction. * P < 0.05.  
No significant difference was found between the IVH and non-IVH infants for the 
transfer function parameters derived from HbO2, HbD or TOI, but the VLF 
coherence of MAP-HHb was significantly lower in the IVH compared with the 
non-IVH infants (P =0.049). Similar results were obtained from the use of 
average coherence within the VLF band (P=0.015) as shown in Table 3-6. The 
time series of MAP, HbO2 and HHb of an IVH infant with low MAP-HHb 
coherence in the VLF range and a non-IVH infant with high coherence were 
illustrated in Figure 3-7 and Figure 3-8.   
65 
 
Table 3-6: Transfer function analysis of mean arterial pressure (MAP) and near-
infrared spectroscopy (NIRS) parameters in the cohort of preterm infants. 
 
IVH Non-IVH P value 
      VLF                  LF    VLF                      LF VLF        LF 
MAP-
HbD 
 
 
Gain 
Phase 
Coh 
CohAV 
 
-0.44±0.11 
0.67±0.69 
0.49±0.06 
0.32±0.07 
 
-0.71±0.12 
-1.12±0.09 
0.68±0.02 
0.44±0.05 
 
-0.40±0.06 
-0.41±0.42 
0.63±0.05 
0.45±0.06 
 
-0.51±0.10 
-0.62±0.27 
0.64±0.03 
0.37±0.04 
 
0.719 
0.190 
0.111 
0.245 
 
0.266 
0.252 
0.353 
0.357 
MAP-
HbO2 
 
 
Gain 
Phase 
Coh 
CohAV 
 
-0.45±0.15 
0.74±0.69 
0.49±0.08 
0.32±0.09 
 
-0.61±0.17-
1.17±0.15 
0.67±0.03 
0.45±0.06 
 
-0.38±0.05 
-0.01±0.51 
0.62±0.04 
0.45±0.05 
 
-0.45±0.09 
-0.44±0.30 
0.67±0.02 
0.43±0.04 
 
0.559 
0.428 
0.128 
0.181 
 
0.355 
0.149 
0.892 
0.824 
MAP-TOI 
 
 
Gain 
Phase 
Coh 
CohAV 
 
-0.35±0.19 
-1.48±0.61 
0.54±0.04 
0.27±0.03 
 
-0.19±0.15 
-0.67±0.47 
0.62±0.02 
0.27±0.04 
 
-0.40±0.11 
-0.10±0.48 
0.56±0.03 
0.31±0.04 
 
-0.19±0.12 
0.57±0.20 
0.62±0.01 
0.30±0.02 
 
0.804 
0.119 
0.691 
0.596 
 
0.979 
0.831 
0.784 
0.428 
MAP-
HHb 
 
 
Gain 
Phase 
Coh 
CohAV 
 
-0.90±0.16 
-0.05±0.69 
0.46±0.08 
0.23±0.04 
 
-0.88±0.26 
-0.28±0.17 
0.65±0.04 
0.38±0.05 
 
-0.69±0.08 
-0.48±0.59 
0.62±0.04 
0.46±0.05 
 
-0.73±0.11 
-0.23±0.29 
0.65±0.01 
0.38±0.03 
 
0.201 
0.679 
0.049* 
0.015* 
 
0.547 
0.293 
0.834 
0.983 
Values are mean ± SEM. HbD, haemoglobin difference; HbO2, oxygenated 
haemoglobin; TOI, tissue oxygenation index; HHb, deoxygenated haemoglobin; 
VLF, very low frequency (0.02-0.04 Hz); LF, low frequency (0.04-0.15 Hz); Gain, 
transfer gain after logarithmic transformation; Phase, transfer phase in rad; Coh, 
coherence; CohAV, average coherence of whole band. * P < 0.05 
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Figure 3-7 : Time series of MAP and relative concentrations of HbO2 and HHb 
in a preterm infant with IVH. Note the highly similar fluctuationsin the very low 
frequency (VLF) range (25-50 s cycle period) in MAP and HbO2, which were 
absent in HHb. This IVH infant had a low MAP-HHb coherence of 0.36 in the 
VLF range.  
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Figure 3-8: Time series of MAP and relative concentrations of HbO2 and HHb 
in a preterm infant without IVH. Note the highly correlated fluctuations in the 
VLF range (25-50 s cycle period) in MAP, HbO2 and HHb. This non-IVH infant 
had a high MAP-HHb coherence of 0.86 in the VLF range.  
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3.3.1 Discussion 
The main finding of this study was that IVH infants had lower VLF coherence 
between BP and cerebral HHb derived from NIRS, along with higher TOI and 
lower FTOE. Parameters derived from transfer function analysis of HbO2, HbD 
and TOI, however, did not show any significant difference between the two 
groups. While our results were seemingly at odds with the expectation that IVH 
infants should have higher coherence [6-8] or gain [5] between BP and NIRS 
measures due to impairment in cerebral autoregulation as postulated by 
previous studies, there were two major methodological differences that should 
not be neglected. First, our findings were derived from the deoxygenated 
hemoglobin HHb, which had not been examined in the past. Second, studies 
which found association between high coherence and incidences of IVH [6, 7] 
were based on the investigation of the very slow trend or the ultra-low frequency 
(ULF) component (<0.02 Hz) using longer measurements (30 min), whereas our 
results were obtained from the VLF component using shorter term 
measurements (10 min). These differences likely accounted for the contrasting 
results. 
Moreover, our findings could be explained based on the physiological conditions 
of the preterm infants. The IVH infants had both higher TOI and lower FTOE 
than the non-IVH. The higher level of cerebral oxygenation in the IVH cases 
should not be seen as a positive sign, as it could well be a consequence of 
impaired oxygen extraction capability. In fact, a recent study also showed that 
cerebral oxygenation on the first day of life was higher in very preterm infants 
compared with healthy term newborns, with the higher TOI again coinciding with 
lower FTOE in the preterm cases [133]. The reduced oxygen extraction was 
very likely to have an impact on the relationship between arterial BP and HHb, 
as the generation of HHb fluctuation was not only dependent on the BP-driven 
blood flow, but also on the oxygen consumption rate in the cerebral capillaries 
which governed the conversion of HbO2 to HHb. It was of interest to note that 
the two IVH infants who had the lowest BP-HHb VLF coherence (0.19 and 0.36) 
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also had rather low FTOE (15% and 8%), suggesting a possible link between 
the two conditions.  
 
3.3.2 Summary  
This study demonstrated that cerebral NIRS measurement was able to provide 
a number of parameters that were potentially useful for distinguishing between 
preterm infants with or without brain hemorrhage. Specifically, IVH infants were 
found to have significantly higher cerebral oxygenation level, lower cerebral 
oxygen extraction rate and lower VLF coherence between arterial BP and 
deoxygenated hemoglobin. Further studies with larger sample size are 
warranted for a more complete understanding of the clinical utility of these NIRS 
measures for early identification of IVH infants.  This study suggests that 
cerebral NIRS measurement may be a suitable monitor of the cerebral 
autoregulation and can provide a non-invasive tool to detect brain haemorrhage 
in preterm infants. 
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Chapter 4. Detrended fluctuation analysis of 
blood pressure in preterm infants with 
intraventricular haemorrhage 
Very preterm infants are at high risk of death and serious permanent brain 
damage, as occurs with intra-ventricular hemorrhage (IVH). Detrended 
fluctuation analysis (DFA), that quantifies the fractal correlation properties of 
physiological signals, has been proposed as a potential method for clinical risk 
assessment. This study examined whether DFA method of the arterial blood 
pressure (ABP) signal could derive markers for the identification of preterm 
infants who developed IVH. This method can also be applied in conjunction with 
the commonly used spectral analysis method to provide a more complete 
description of the underlying cardiovascular dynamics, which can help to avoid 
any unfavourable events in the near future. 
In this chapter, we present the DFA approach to evaluate the fractal dynamics 
embedded in the arterial pressure waveform, which might provide important 
information in the early detection of IVH in preterm infants. Section 4.1 starts 
with the basic background about DFA method. Section 4.2 lists the materials 
and methods used in this chapter. The results from DFA of MAP, SBP and 
pulse interval are presented in section 4.3. Section 4.4 presents a detailed 
discussion of results. The limitations are discussed in section 4.5 and 
conclusions are drawn in section 4.6. 
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4.1 Introduction 
With advancements in neonatal intensive care, the incidence of IVH has fallen 
from 30% in the 1980’s to 6 % [12] in preterm infants with very low birth weight 
(birth weight ≤1500 g). Rates of IVH and in particular severe grades of IVH with 
extension into cerebral tissue (grade V IVH) in the Papille system are still a 
major concern in those extremely preterm infants (<27 weeks gestation) [13]. 
Fragile cerebral circulation of preterm infants is affected by fluctuations in the 
systemic circulation associated with the pathophysiology of preterm birth and 
the first six hours of life when complex interactions occur between mechanical 
ventilation and the circulation. Preterm birth <27 weeks is an abnormal event 
often precipitated by maternal infection, bleeding or hypertension, factors all 
predisposing to reduced uterine perfusion and thus placental function. Placental 
dysfunction is a predisposing factor to the fragile blood vessels in the germinal 
matrix bleeding in a grade I IVH. If this extends into the ventricular system 
(grade II IVH) and then blocks the needed drainage of ventricular fluid via the 
third and fourth ventricles (grade III IVH), risks of long-term brain damage rise. 
Venous occlusion in adjacent areas of the cerebral hemispheres can give rise to 
infarction and significant injury to major motor tracks leading to cerebral palsy or 
intellectual impairment [1, 30]. The timing of IVH indicates most hemorrhages 
develop after birth with such factors as resuscitation and cardiorespiratory 
management during the first 24 hours of life being important in the causal 
pathway [2],[14],[15],[35],[36]. Thus the ability to identify preterm infants with 
IVH at an early stage is of great importance in terms of minimizing mortality and 
morbidity in the neonatal intensive care setting. 
A recent study explored the potential application of detrended fluctuation 
analysis (DFA) for identifying early subtle alterations of heart rhythm that could 
be predictive of impending IVH in very low birth weight babies [21]. DFA has 
been regarded as a robust method to quantify the scale-invariant (fractal) 
correlation property of a time series, especially when the signal class cannot be 
precisely determined. Specifically, this method characterises the mono-fractal 
property. Previous studies have adopted this method to evaluate the fractal 
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dynamics of heart rate in various diseases in adult subjects [16, 17]. The DFA 
method aims at measuring the intrinsic fractal-like correlation properties or self-
affinity of the time series, characterized by increasing magnitude of fluctuations 
with increasing time scale (or decreasing frequency). The degree of fractal 
scaling can be depicted by the scaling exponent (α) that quantifies the 
relationship between fluctuations F(n) and time scale n based on the 
mathematical function F(n) =   , with α = 1 corresponding to the classical 1/f 
fractal signal [16, 17]. In a prior study, preterm infants who later developed IVH 
were found to have significantly higher short-term scaling exponent of heart rate 
compared with those who did not develop IVH [21]. The differing fractal 
dynamics of heart rate in these two groups of infants have been attributed to the 
altered autonomic control of the heart associated with the development of IVH. 
Assessment of fractal scaling properties in ABP in adult humans based on DFA 
method has also been reported [18-20]. By performing autonomic blockade 
tests, it was shown that vagal blockade by atropine could lead to an increase in 
the short-term scaling exponent of BP, whereas central blockade of both 
cardiac and vascular sympathetic outflow by clonidine would result in a 
decrease of the exponent [20]. It was therefore suggested that fractal dynamics 
of arterial pressure were largely influenced by the autonomic nervous system 
activity. However, the fractal scaling of arterial BP in preterm infants has not 
been investigated previously. 
In this study, we examined whether there was a difference in fractal scaling 
exponents derived from DFA of arterial BP between preterm infants with and 
without IVH. It was hypothesized that the infants who developed IVH might have 
higher fractal scaling exponents of arterial BP, similar to that seen in heart rate 
fluctuations [21]. The findings could help to establish the potential value of 
fractal dynamics embedded in the arterial pressure waveform for early 
identification of brain hemorrhage in preterm infants. 
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4.2 Methods 
This was a prospective clinical investigation, carried out in a large tertiary 
neonatal intensive care unit in Sydney, Australia. The study was approved by 
the Sydney West Area Health Service Human Research and Ethics and 
conducted according to the World Medical Association Declaration of Helsinki 
and informed parental consent was obtained in all cases. The cohort comprised 
early low birth weight infants with gestational age <30 wk, without significant 
congenital anomalies who survived at least 2 hours. This is a standard caveat 
for clinical newborn research that infants with significant congenital anomalies 
are a very heterogeneous group at high risk of death or long-term neuro-
disability, both outcomes of interest to the study, hence restriction of entry 
criteria.The exclusion of infants with significant anomalies is standard in 
neonatal research to reduce confounding from congenital factors strongly 
associated with mortality or long-term disability such as trisomy 13. A single 
measurement of data with 10 min continuous artefact-free segment from each 
baby was used for analysis. Out of the 46 infants enrolled in the study, 30 
infants had arterial BP recordings with sufficiently long artefact-free segments 
suitable for analysis. The remaining 16 infants either did not have BP recordings 
(9 infants) or had considerable amount of artefact in the BP data (7 infants). 
4.2.1 Measurements 
Physiological data were collected from the infants within 1-3 hours of birth.  
Intra-arterial BP was measured via an umbilical or peripheral arterial catheter 
connected to a transducer calibrated to atmospheric barometric pressure and 
zeroed to the midaxillary point. The BP signal was continuously acquired via a 
bedside patient monitor (Philips Agilent Systems, Philip Healthcare, North Ryde, 
Australia), and recorded by a data acquisition system (ADInstruments, Sydney, 
Australia) at a sampling rate of 1 kHz. The LabChart software (ADInstruments, 
Sydney, Australia) provided automatic beat-to-beat computation of 
systolic blood pressure (SBP), MAP and pulse interval from the arterial BP 
waveform. Cranial ultrasound measurements for the diagnosis of IVH were 
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taken within the first 2 hours of life and repeated 12 hourly for the first 2 days of 
life. The scans and assessments were taken in a systematic method with 
classification scored by a pediatric radiologist blinded to the clinical outcome 
and study according to the Papille classification [13].   
4.2.2 Data analysis 
DFA was performed on uninterrupted data recordings of 10 minutes (obtained 
within 1-3 hours after birth from each infant) without noticeable corruption by 
artefacts. All signal processing was implemented in Matlab (Natick, MA, USA). 
Spikes in the beat-to-beat time series due to occurrence of abnormal pulse 
intervals (e.g. prolonged heart period resulting from a missing beat), which 
constituted less than 3% of the total number of beats, were removed and 
replaced by linear interpolation of the beat values immediately preceding and 
following the replaced beats. 
The DFA method has been developed to analyze the scale-invariant (fractal) 
correlation property of a time series [16]. In this case, the time series would 
correspond to the beat-to-beat values of SBP, MAP and pulse interval. Consider 
a time series Y with a total length of N, i.e. a total of N beats. For a heart rate of 
150 bpm, a 10 minute period would consist of N = 1500 beats. In the application 
of DFA, the time series was first integrated to improve the fractal property. This 
is achieved by calculating the cumulative sum of the differences between the ith 
parameter value Y(i) and the mean parameter value Ymean: 
     ∑ [          
 
   ]                                                                                (4.1)                                                                     
Next, the integrated time series y(k) is divided into multiple windows of equal 
length n. For example, for a total of N = 1500 beats and for a window size of n = 
15 beats, there would be 100 windows. Within each window, a trend line is fitted 
to the data, with yn(k) denoting the k
th point on the trend line with a length of n. 
The root-mean-square (RMS) fluctuation F(n) of the detrended integrated time 
series for a given window size n is calculated by  
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This procedure is repeated at different window sizes to derive the relationship 
between F(n) and n. Finally, F(n) is plotted against the window length n in a log-
log plot, and the slope of the relationship will correspond to the fractal scaling 
exponent α. For fractal signals, the fluctuations can be expressed as a power-
law function of the time scale:  F(n) = Cnα, in which case log10(F(n)) and log10(n) 
are directly proportional with α as the slope of the relationship. The existence of 
a linear relationship (assessed by the goodness of fit of the regression) between 
log10(F(n)) and log10(n) will be considered necessary for the slope α to be a 
valid measure of fractal scaling. The special case of α = 1 is often termed 1/f 
noise, with the power of fluctuations being linearly related to the time scale. The 
1/f noise has been frequently observed in nature and in various biological 
phenomena, although the physiological mechanism behind remains speculative. 
Examination of the DFA plot of heart rate has suggested the existence of two 
linear regions with different fractal slopes separated by a breakpoint nbp [140] – 
the first region covered the range from 4 to nbp beats, characterized by a short-
term scaling exponent α1; the second region covered the range from nbp to 50 
beats, characterized by a long-term scaling exponent α2. As the previous infant 
study has found that the 8-15 beats range of heart period fluctuation appeared 
to provide most useful information in relation to IVH [21], nbp was chosen to be 
15. Therefore, the short-term scaling exponent α1 was calculated from a window 
size of 4-15 beats, whereas the long-term scaling exponent α2 was calculated 
from a window size of 15-50 beats. 
The results for the cohort were presented as mean ± SD. Differences between 
the IVH and non-IVH infants were compared with the Student’s t test. A P value 
of <0.05 was considered significant.  
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4.3 Results 
The demographic and clinical characteristics of the studied infants are 
presented in Table 4-1: Physiological variables in the cohort of preterm infants. 
Out of the 30 infants studied, 26 infants were mechanically ventilated, 10 infants 
suffered from IVH and 2 infants died eventually (one infant did not suffer from 
IVH). Thus, there were 10 infants with IVH (9 of whom were ventilated) and 20 
infants without IVH (17 of whom were ventilated) in our cohort. Note that there 
was no significant difference in the SBP, MAP, heart rate and CRIB II score 
(CRIB stands for Clinical Risk Index for Babies [141],[4]) between the two 
groups of infants. Out of the 16 infants excluded from the analysis, 3 infants 
suffered from IVH and 2 infants died eventually (one infant did not suffer from 
IVH).  
The results from DFA of MAP, SBP and pulse interval are shown in table 4-2 
and in table 4-3 (for the infants with mechanical ventilation). For both the short-
term and long-term beat ranges, the regression fit R2 was high (>0.9), which 
justified the validity of the DFA approach. The group averages of the DFA log-
log plot for MAP in the short-term and long-term beat ranges are shown as 
Figure 1a and 1b respectively.  For the IVH infants, the short-term scaling 
exponents α1 of both MAP and SBP were significantly higher than those of the 
non-IVH infants (P = 0.017 and P = 0.038 respectively), and also closer to 1, 
that signifies 1/f fractal scaling. Similar results were seen in the infants with 
mechanical ventilation only (P = 0.007 and P = 0.020 for the α1 of MAP and 
SBP respectively). No significant difference was found between IVH and non-
IVH in the long-term scaling exponent α2 of MAP and SBP, and in both cases α2 
appeared to be slightly above 1. No difference was found in either the short-
term or long term scaling exponents for pulse interval. 
4.4 Discussion 
This study is the first to examine the fractal dynamics of arterial BP in preterm 
infants using the DFA approach. The rationale was to address whether the 
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fractal scaling of arterial BP could provide potentially useful information for 
distinguishing between preterm infants with and without brain hemorrhage. The 
main finding is that the short-term fractal scaling exponent α1 is significantly 
higher in the IVH infants compared with the non-IVH infants. This finding 
suggests that fractal dynamics embedded in the arterial pressure waveform 
might hold important information that could allow early identification of preterm 
infants at risk of developing significant IVH after birth and led to further studies 
to examine ways of reducing the risk using this new information. In addition, the 
high R2 (> 0.9) in the DFA model fit provides validation to the appropriate use of 
this technique for analyzing fractal scaling in the BP fluctuation of infants. 
The study of fractal scaling in arterial BP in adult humans using the DFA 
approach has revealed important contributions of the autonomic nervous 
system in the scaling exponents [20]. It was shown that blockade of vagal 
activity by atropine could lead to an increase in the short-term scaling exponent 
of BP. The main reason was believed to be the removal of heart rate variation 
that was being translated to BP fluctuation, specifically those generated by the 
respiratory modulation of cardiac vagal activity. As the heart beat intervals 
govern the period of diastolic decay in the arterial pressure pulse (the 
Windkessel mechanism) and also the diastolic filling of the heart (that 
determines stroke volume), they would have direct effects on DBP and SBP. 
Thus, smoother heart rate fluctuations could result in smoother BP fluctuations. 
Conversely, the administration of clonidine, that causes central blockade of both 
cardiac and vascular sympathetic outflow and a central increase in cardiac 
vagal activity, resulted in a decrease of the short-term BP exponent. The higher 
α1 observed in the IVH infants might therefore be explained by either a 
reduction of vagal activity or an augmentation of sympathetic outflow compared 
with the non-IVH infants.  
The use of mechanical ventilation was likely to be an important factor for the 
association between the short-term scaling exponent α1 and IVH, given its 
influence on the respiratory fluctuation of BP and heart rate. In this cohort of 
preterm infants, a majority were breathing with mechanical ventilation (26 out of 
30), and only a small number were breathing spontaneously (1 IVH and 3 non-
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IVH). The separate analysis performed on the mechanically ventilated subgroup 
showed similar results as the whole group (Table 4-3) with the IVH infants 
having higher α1 than the non-IVH infants. In fact, the P values obtained were 
even smaller, thus it was possible that the use of mechanical ventilation could 
be a reason for the observed association between α1 and IVH. Unfortunately, 
the number of infants without mechanical ventilation was too low in this study 
for statistical analysis. Whether the ventilatory mode had any direct impact on 
the results would need to be addressed by further studies with larger sample 
size. Early studies have also strongly implicated the causal association of lack 
of patient to ventilator synchrony causing intraventricular haemorrhage [142, 
143]. These studies occurred prior to the current methods of patient triggered 
ventilation and used paralytic agents to prevent adverse patient breathing 
interaction with the ventilator.  
A previous study examined the use of DFA on the fluctuation of heart period (R-
R) interval measured by electrocardiogram (ECG) in preterm infants suffering 
IVH [21]. The short-term scaling exponent (α1) computed from the 8-15 beat 
range was found to be significantly higher in the infants who later developed 
IVH compared with those who did not. In the current study, the pulse interval 
extracted from the arterial BP waveform was used as a measure of heart period 
fluctuation, but no significant difference was found between the IVH and non-
IVH infants. A possible reason could be the difference between R-R interval 
variability and pulse interval variability, particularly in the high frequency range 
(respiratory frequency) [144], that corresponded to the time scale of the short-
term exponent α1.  
Based on a previous study using pharmacological intervention, our observation 
of an increase in the scaling exponent of BP can be best explained by a 
suppression of vagal activity. The reduction in heart rate fluctuation due to lack 
of cardiac vagal activity may lead to the reduction in BP fluctuation, as heart 
period can have direct effect on BP via the Windkessel mechanism. Vagal 
activity is known to be involved in the regulation of cerebral blood flow, but the 
exact mechanism through which IVH is linked with vagal activity remains 
unclear thus far. 
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Nevertheless, the higher α1 found in the BP fluctuation of IVH infants was in 
agreement with the previous finding, both of which suggested a lack of vagal 
activity or an augmentation of sympathetic outflow compared with the non-IVH 
infants. Vagal nerve activity has been shown to play an important role in the 
regulation of cerebral blood flow during hemorrhage and cerebral ischemia 
[145]. Results from the current work have provided further evidence that 
development of IVH could involve impairment in parasympathetic outflow. 
However, the specific mechanism through which IVH is linked with vagal activity 
remains unclear thus far.  
While it has been previously demonstrated that DFA of heart period (derived 
from ECG) could provide useful information for the identification of IVH [21], 
there are still potential benefits from the use of arterial BP. Firstly, it is not 
completely clear whether the fractal dynamics of arterial BP simply follow the 
heart period, or represent additional mechanism that is not assessable from the 
DFA of heart period alone. Secondly, from the clinical viewpoint, it is not yet 
known which method may provide more relevant information for the detection of 
IVH, or whether the two methods can be applied together to improve the 
accuracy of detection. This would require further studies with simultaneous 
ECG and BP recordings in a larger cohort. Thirdly, it may be preferable to use 
arterial BP instead of ECG in situations where movement artefacts from the 
infants have led to degradation of ECG quality, such that sufficiently long 
artefact-free segments are not obtainable.   
There are several advantages from deriving clinical information using the DFA 
method. Firstly, this method can be performed on an acceptable duration of 
data (10 min in this case), that is practical in the neonatal intensive care setting. 
Secondly, the information (namely the scale exponent) is derived from a specific 
beat range,that can be easily translated to a similar time range or frequency 
band used in other methods such as power spectrum analysis. This would 
largely facilitate the physiological interpretation of the derived parameters. 
Thirdly, it can be applied in conjunction with the commonly used spectral 
analysis method to provide a more complete picture of the underlying 
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cardiovascular dynamics, as both methods can provide complementary 
information [20]. 
 
Table 4-1: Physiological variables in the cohort of preterm infants 
 IVH Non-IVH   P Value  
Gestational age 
(wk) 
26.7±1.7 26.9±1.9      0.79  
Birth weight (g) 1023±357 1025±340      0.99  
CRIB II score 10±3 10±3      1  
MAP (mmHg) 35.1±6.0 35.2±5.3      0.97  
SBP (mmHg) 45.1±9.6 43.6±6.5      0.62  
Heart rate (bpm) 139±8 144±10      0.11  
Pulse interval (ms) 353±146 402±65      0.21  
Values are mean ± SD. CRIB, Clinical Risk Index for Babies; SBP, systolic 
blood pressure; MAP, mean arterial pressure. 
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Table 4-2: Detrended fluctuation analysis (DFA) of mean arterial pressure 
(MAP), systolic blood pressure (SBP) and pulse interval (PI) in the cohort of 
preterm infants (N = 30). 
  
IVH  
(N = 10) 
Non-IVH  
(N = 20) 
P Value 
 
                    
MAP α 1.060.18 1.21±0.16 0.84±0.25 1.11±0.19 0.017* 0.152 
 R
2 
0.980.02 0.97±0.02 0.99±0.01 0.980.02 0.362 0.386 
SBP α 0.980.20 1.17±0.15 0.78±0.25 1.06±0.21 0.038* 0.145 
 R
2 0.980.01 0.97±0.03 0.99±0.01 0.97±0.03 0.538 0.461 
PI α 0.73±0.35 1.06±0.25 0.64±0.37 0.96±0.38 0.546 0.459 
 R
2 0.99±0.01 0.97±0.02 0.97±0.03 0.95±0.06 0.190 0.166 
Values are mean ± SD.  α1, short range scaling exponent (4-15 beats); α2, long 
range scaling exponent (15-50 beats); α, DFA scaling exponent; R2, goodness 
of fit of the linear regression in DFA. * P < 0.05 between IVH and non-IVH.  
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Table 4-3: Detrended fluctuation analysis (DFA) of mean arterial pressure 
(MAP), systolic blood pressure (SBP) and pulse interval (PI) in the cohort of 
preterm infants with mechanical ventilation (N = 26). 
  
IVH ventilated 
(N = 9) 
Non-IVH ventilated 
(N = 17) 
P Value 
 
                    
MAP α 1.05±0.18 1.22±0.17 0.79±0.23 1.09±0.18 0.007* 0.093 
 R
2 
0.99±0.01 0.99±0.01 0.99±0.01 0.99±0.01 0.631 0.756 
SBP α 0.94±0.17 1.16±0.16 0.73±0.22 1.03±0.20 0.020* 0.092 
 R
2 0.99±0.01 0.99±0.01 0.99±0.01 0.99±0.02 0.928 0.871 
PI α 0.66±0.30 1.04±0.26 0.66±0.40 0.93±0.41 0.970 0.482 
 R
2 0.99±0.01 0.99±0.01 0.99±0.01 0.97±0.03 0.201 0.146 
Values are mean ± SD.  α1, short range scaling exponent (4-15 beats); α2, long 
range scaling exponent (15-50 beats); α, DFA scaling exponent; R2, goodness 
of fit of the linear regression in DFA. * P < 0.05 between IVH and non-IVH.  
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Figure 4-1: The plot of Log10(F(n)) vs Log10(n) from detrended fluctuation 
analysis (DFA) of mean arterial pressure (MAP) for infants with intraventricular 
hemorrhage (IVH) and those without (non-IVH), in the short-term beat range (n 
= 4-15 beats). The mean and SEM of the groups are shown. The short-term 
scaling exponents (α1) are computed as the linear slopes of the individual plots. 
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Figure 4-2: The plot of Log10(F(n)) vs Log10(n) from detrended fluctuation 
analysis (DFA) of mean arterial pressure (MAP) for infants with intraventricular 
hemorrhage (IVH) and those without (non-IVH), in the long-term beat range (n = 
15-50 beats). The mean and SEM of the groups are shown. The long-term 
scaling exponents (α2) are computed as the linear slopes of the individual plots. 
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4.5 Limitations 
There are some limitations to this study. Firstly, due the relatively low incidence 
of IVH in our cohort it was not possible to assess how the DFA exponents relate 
to the severity of hemorrhage. Secondly, the data duration of 10 min placed a 
limitation on the longest beat range that can be assessed by DFA method. It 
would be desirable that these limitations could be overcome in future by 
improvement in the experimental design. 
4.6 Summary 
In conclusion, this study examined whether the application of DFA method on 
the arterial BP signal could derive markers for the identification of preterm 
infants who developed IVH. The results showed that the IVH infants had higher 
short-term scaling exponents of both MAP and SBP compared to the non-IVH 
infants. Thus, fractal dynamics in arterial BP could provide potentially useful 
information that facilitates early identification of IVH in preterm infants. Further 
studies with larger sample size are warranted for a more complete 
understanding of the clinical utility of these ABP measures for early 
identification of IVH infants.   
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Chapter 5. Estimation of Cardiac Output 
and Total Peripheral Resistance by Arterial 
Waveform Analysis  
 
The purpose of monitoring tools of cardiac output (CO) and total peripheral 
resistance (TPR) in this chapter is to continuously provide valuable information 
about the overall haemodynamic state of the preterm infants. Based on this 
information, the doctor can decide whether the patients need intensive care and 
monitoring. However, in the present NICU setting, the assessment of CO and 
TPR requires specialized skill and equipment, and cannot be performed 
continuously.  
In section 5.2, we firstly explored the possible ways of using the diastolic decay 
rate parameter for assessing LVO and TPR in preterm infants. In section 5.3  to 
further improve the accuracy and robustness of the estimation, a multivariate 
regression model with the inputs of features from the arterial BP waveform 
analysis were used to estimate the LVO and TPR. 
5.1 Introduction 
Cardiac output and total peripheral resistance are two important parameters of 
the cardiovascular system. Measurement of these two parameters can provide 
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valuable information for the assessment and management of patients needing 
intensive care, including preterm infants in the NICU [22, 23]. For example, high 
CO and low TPR are symptoms of sepsis, which is a common cause of 
mortality and morbidity in preterm infants, particular those with very low birth 
weight (VLBW) [22]. A substantial drop in CO (>50%) has been associated with 
a high risk of mortality in these infants with sepsis [22]. Furthermore, the 
measurement of systemic hemodynamics can facilitate the development of 
better therapeutic strategy for these infants, including the use of volume 
expansion and inotropes [23]. In the present NICU setting, the assessment of 
CO and TPR requires the measurement of left ventricular outflow (LVO) or right 
ventricular outflow (RVO) using ultrasound Doppler echocardiographic 
waveforms. However, such measurement requires specialized skill and 
equipment, and cannot be performed continuously.  
In this study, the estimation of LVO and TPR was performed by analyzing the 
rate of blood pressure decay in the diastolic portion of the arterial pulse wave. 
This has been associated with TPR in the Windkessel model, and has been 
utilized in the study of animals and adult patients [4, 5]. However, whether this 
arterial waveform parameter is useful for monitoring preterm infants has not 
been previously investigated. The results from the current study would help to 
establish the potential utility of the diastolic decay rate parameter for assessing 
LVO and TPR in preterm infants. 
The arterial tree is a complex system not only because of its geometry but also 
because of its nonlinear mechanical properties. Thus biophysicists and 
physiologists have been trying to develop simplified representations of this 
system to describe some of its functional aspects. Some characteristics of the 
mechanical properties of the whole arterial tree can be derived from the 
continuous measurements of aortic arterial pressure (AP) and blood flow. 
Among the parameters that can be estimated in the most straightforward way 
for each cardiac cycle, the vascular resistance (R), computed as the ratio of 
MAP to mean aortic flow, and the time constant of the diastolic AP decrease 
according to a monoexponential model (t) are the simplest and the most 
interesting ones. According to Poiseuille’s law with the assumptions of a 
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Newtonian fluid and a laminar flow in a cylindrical tube, R contributes to the 
dissipation of the circulatory energy in the arterial tree during each cardiac cycle. 
The time constant signals the restoration of energy stored by the arterial wall 
during the elastic distension due to ventricular ejection. The determination of 
this time constant depends on the accuracy of the exponential fit of the diastolic 
part of the AP curve. Such a model based on the windkessel effect has been 
widely used, and numerous studies have been performed to improve it and to 
better estimate and interpret the model parameters.  
5.2 Arterial Waveform Analysis of Arterial BP waveform 
5.2.1 Methods 
5.2.1.1 Subjects 
This was a prospective clinical investigation, carried out in the neonatal ICU at 
the Nepean Hospital in Sydney, Australia. The study was approved by the 
Sydney West Area Health Service Human Research and Ethics Committee, and 
informed parental consent was obtained in all cases. 
The cohort comprised early low birth weight infants with gestational age <30 
wks, without significant congenital anomalies who survived at least 2 hours. A 
single measurement of data with 10 min continuous artefact-free segment from 
each baby was used for analysis. The study cohort comprised a convenience 
sample of 27 early low birth weight infants with gestational age <30 wks. The 
demographic characteristics of the studied infants are as follows (mean±SD): 17 
males 12 females, gestational age 26.7±1.8 wks (range 24-30 wks), birth weight 
1010.7±346.3 g (range 520-1929 g). 
Physiological data were collected from the infants at four different time periods:  
1-3 hours after birth (27 babies), 12 hours after birth (24 babies), 24 hours after 
birth (20 babies) and 36 hours after birth (18 babies). Thus a total of 89 
measurements were used in the modeling. 
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5.2.1.2 Measurements 
Arterial BP waveform was acquired via a bedside patient monitor (Philips 
Agilent Systems, Philip Healthcare, North Ryde, Australia). Intra-arterial BP was 
continuously measured via an umbilical or peripheral arterial catheter connected 
to a transducer calibrated to atmospheric barometric pressure and zeroed to the 
midaxillary point. A Vivid 7 Dimension ultrasound scanner (GE Health Care, 
Rydalmere, Australia) was used with a 5–7 MHz sector cardiac probe 
incorporating pulsed wave and continuous Doppler echocardiographic 
waveforms. All ultrasounds were performed by the same investigator (M.T.).  
LVO was obtained by measuring the aortic valve annulus diameter in the 
parasternal long axis view, and then velocity time integrals (VTI) were obtained 
with a minimum of 5 consecutive aortic pulsed Doppler waveforms from an 
apical long axis view  [38]. 
 
5.2.1.3 Signal processing and feature extraction 
 
ABP signals were low-pass filtered at cut-off frequencies of 50 Hz respectively 
to remove undesirable high-frequency noise.   
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Figure 5-1: ABP signals before and after low-pass filtering. 
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The ABP pulses of preterm infants typically follow an exponential decay during 
each diastolic interval. As mentioned in section 2.5.1, the Windkessel model  of 
the systemic circulation comprises elements of arterial resistance (R) and 
arterial compliance (C), the time constant of this exponential decay (τ) 
corresponds to RC [146, 147]. Assuming that C was similar amongst the infants 
(as C changed mainly with age and the infants should have very compliant 
arteries at birth), while R could vary greatly depending on the infants’ condition, 
and thus the main determinant of τ would be R. For each cardiac cycle, CO 
(measured as LVO here) was related to R via the relationship  
   
  
.Therefore, 
it was hypothesized in this study that there is a relationship between CO and 1/τ. 
In addition, there may be a stronger relationship between CO and MAP/τ, 
assuming that τ represents R. 
All signal processing and feature extraction was implemented in Matlab (Natick, 
MA, USA). The time constant  was estimated beat to beat using the 
exponential decay time method [148-150] by the model shown as follows: 
          
 
 
                                                                                              (5.1) 
where t is time and     is the AP value at time 0 which is the initial time for 
application of the model. The last one-third of the AP curve was utilized in this 
model and a linear regression was developed after logarithmic transformation of 
AP values, which yielded a correlation coefficient (  ) that indicated the quality 
of the exponential regression. The slope of the regression line was   ⁄  and 
systemic arterial compliance was calculated using the windkessel relationship 
    ⁄ . 
From each cardiac pulse of the pressure waveform, the diastolic decay time 
constant τ of the Windkessel model was determined by fitting an exponential 
function to the diastolic period [146]. The fitted curves are illustrated in Figure 
5-2 and Figure 5-3.A direct way of extracting the exponential time constant was 
to take the logarithm of both pressure and time and carry out linear regression, 
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then the slope of the regression would be 1/τ, termed the diastolic decay rate. 
Figure 5-2 shows an example of a relatively slow decay rate (long time constant) 
whereas Figure 5-3 shows an example of a fast decay rate (short time constant). 
This slope parameter was first determined in each set of measured data by 
taking the mean value of 50 pulses. Finally, the relationship of LVO (and TPR) 
with 1/τ was examined by linear regression using the 89 sets of measurements, 
and the corresponding correlation coefficient r was computed. 
As a comparison, another parameter given by the product of pulse pressure and 
heart rate (PP × HR) was derived, and its relationship with LVO was examined. 
This parameter has previously been used to track LVO changes in adult 
subjects [151].   
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Figure 5-2: Arterial blood pressure (ABP) pulses with the fitted exponential 
functions, for one subject with a diastolic decay rate of 0.44 Hz (time constant of 
2.3 s). 
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Figure 5-3: Arterial blood pressure (ABP) pulses with the fitted exponential 
functions, for one subject with a diastolic decay rate of 1.24 Hz (time constant of 
0.8 s).   
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5.2.2 Results 
The results of regression analysis demonstrate that the diastolic decay rate 1/τ 
had a significant positive relationship with LVO (r = 0.383, P = 0.0002), and 
negative relationship with TPR (r = -0.379, P = 0.0002). The corresponding 
scatter plots are shown in Figure 5-4 and Figure 5-5. It was noted that one 
subject had a much higher decay rate (1/τ = 1.8 Hz) compared to others, and if 
this subject was neglected the correlations would become stronger (for LVO, r = 
0.435, P = 0.00002; for TPR, r = -0.437, P = 0.00002). Overall, the results have 
shown that the diastolic decay rate parameter was potentially useful for 
providing information about LVO and TPR in the preterm infants. Although the 
correlations were not high, the scatter plots (Figure 5-4and Figure 5-5) seem to 
suggest that the relationships between the variables may be better described by 
a more complex nonlinear function rather than a simple linear one. This could 
be further explored in future to improve the accuracy of estimation.   
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Figure 5-4 : Left ventricular outflow (LVO) versus diastolic decay rate (1/τ) in 
the cohort of preterm infants. 
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Figure 5-5: Total peripheral resistance (TPR) versus diastolic decay rate (1/τ) in 
the cohort of preterm infants. 
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The individual exponential fit to the ABP pulses displayed high R2 (0.99 ± 0.01), 
which provided justification of the Windkessel model for the analysis of pressure 
waveforms in infants. While previous studies have demonstrated the utility of 
the Windkessel-model based approach for the hemodynamic monitoring of 
animals and adult patients [4, 5], the current study was the first to demonstrate 
its potential value for the assessment of preterm infants in the NICU setting. It 
has been suggested that in normal adults, the presence of arterial pulse wave 
reflection may affect the accuracy of the Windkessel model [5]. However, it 
appears that in the preterm infants, wave reflection is not prominent as the 
arterial pulses often do not display clear secondary peaks (Figure 5-2 and 
Figure 5-3). This may explain the good fit achieved by a simple Windkessel 
model.  
The parameter MAP/τ (MAP × diastolic decay rate) had lower correlation with 
LVO (r = 0.266, P = 0.012) compared with 1/τ, as shown in Figure 5-6. If the 
outlier with a very high decay rate (1/τ = 1.8 Hz) was excluded, the correlation 
became higher (r = 0.299, P = 0.0046). According to the model, MAP/τ should 
have a stronger relationship with CO compared with 1/τ, but the data seemed to 
suggest otherwise which was unexpected. Another arterial waveform parameter 
PP × HR did not show any significant correlation with LVO (r = 0.066, P = 0.54). 
Thus this parameter is probably more suitable for monitoring intra-subject 
change [151] but not for estimating CO in a group of preterm infants.   
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Figure 5-6: Left ventricular outflow (LVO) versus the product of mean arterial 
pressure and diastolic decay rate (MAP/τ) in the cohort of preterm infants.  
 
 
Figure 5-7: Left ventricular outflow (LVO) versus the product of pulse 
pressure and heart rate (PP × HR) in the cohort of preterm infants.   
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5.2.3 Discussion 
Many extremely low birth weight infants have impaired cerebral autoregulation 
(some with a complete absence of autoregulation) and thus a pressure passive 
cerebral circulation. Intracranial haemorrhage is more likely in this state of 
pressure passive circulation.  Routine methods of estimating cardiac function in 
these preterm infants  are dependent on echocardiographic estimates of 
volumetric flow or M-Mode estimates of ejection fraction. There are obvious 
limitations with the need of appropriately trained clinicians to perform these 
examinations and those measurements are valid for the short time period of the 
examination. There is thus an urgent need to explore new methods of 
continuous estimates of cardiac function to support clinical decisions to treat 
hypotension and support vulnerable cerebral circulation.     
5.3 Multivariate regression Model 
5.3.1 Introduction 
The preliminary results from this study demonstrated the potential utility of 
arterial pressure waveform analysis for estimating LVO and TPR in preterm 
infants. However, to further improve the accuracy and robustness of the 
estimation, more advanced multi-parameter models may be needed. Such 
models could include additional physiological parameters such as heart rate as 
well as incorporating possible nonlinear relationships between the parameters. 
5.3.2 Multivariate regression  
In this study, multivariate regression was used to model the relationship 
between the extracted features and the measurement of LVO and TPR, by 
fitting a linear least square equation. The LVO and TPR were estimated as a 
weighted sum of a chosen subset of k features, by means of linear least square 
modelling. In the following discussion, the unknown variable to be estimated is 
assumed to be LVO, but the methods are equally applicable to estimate TPR. 
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In this model, for each subject of LVO,   , i=1,2,…,N ( the number of subjects) is 
a linear function of all k input features.  
                          (5.2) 
The estimated output from the model   ̂ is assumed to be related to the 
extracted features      [             ]
 , where we write     for the  
   feature 
variable measured for the     subject, by a set of weight   [          ]
 and a 
constant      is shown as follows: 
  ̂    
          (5.3) 
In matrix form, 
 ̂             
=[  | ]  
= ̃                                         (5.4) 
where  ̂ is a column vector and the     row of   ̂,   ̂, is the LVO of the  
   subject; 
 ̃ is a matrix with the     row representing the k features of the j-th subject 
augmented with a column of ones, 1; and   = [               ]
  . 
The vector of weights,   , which defines the LVO least square model for the k 
features, can be calculated by the function  as follows: 
   ̃  ̂     (5.5) 
where  ̃  is the Moore-Penrose pseudoinverse of the matrix ̃. 
The mean-squared error (MSE) between the measured and the estimated 
variables(LVO and TPR) of the model is calculated as follows: 
    
 
 
∑    ̂     
  
                                                                                        (5.6) 
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where    is the measurement of LVO and TPR for the  
   subject. In the next 
section, the MSE will be used to estimate of how well the estimated LVO,  ̂ , 
agrees with the LVO measurement. 
 
5.3.3 Methods 
5.3.3.1 Database 
A group of 89 physiological data were collected from the infants at four different 
time periods were used in the modeling, as mentioned in section 5.2.1. Intra-
arterial BP was measured via an umbilical or peripheral arterial catheter 
connected to a transducer calibrated to atmospheric barometric pressure and 
zeroed to the midaxillary point, as mentioned in section 5.2.1.2. The BP signal 
was continuously acquired via a bedside patient monitor (Philips Agilent 
Systems, Philip Healthcare, North Ryde, Australia), and recorded by a data 
acquisition system (ADInstruments, Sydney, Australia) at a sampling rate of 1 
kHz. ABP was measured invasively using a radial artery catheter, and the 
LabChart software (ADInstruments, Sydney, Australia) provided automatic 
computation MAP and PP from the ABP. Spikes in the beat-to-beat time series 
due to occurrence of abnormal pulse intervals (e.g. prolonged heart period 
resulting from a missing beat), which constituted less than 3% of the total 
number of beats, were removed and replaced by linear interpolation of the beat 
values immediately preceding and following the replaced beats. 
The derivation of various MAP features and their respective meanings have 
been explained in detail in the section 5.2.1.1.The diastolic decay rate of ABP 
(1/), MAP, PP, MAP × diastolic decay rate of ABP (MAP/), PP × HR，HR 
features are selected to build the model.  
5.3.3.2 Features selection 
The squared and cubed value, as well as the logarithms of each feature is 
added into the feature pool to extend the 6 existing features to a total of 24 
features. These transformed features are included to ensure any non-linear 
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relationship between the features and the LVO&TPR is captured by the 
multivariate model. 
To study the usefulness of the diastolic decay rate to estimate LVO and TPR, 
features not directly derivable from the diastolic decay rate were removed from 
the feature pool when the feature selection algorithm was executed. The 
performances of the regression models selected in these two cases were 
compared to the model found from the complete feature pool. 
A stepwise linear regression model was used to map an optimal feature subset 
to the LVO and TPR score, and the decision to add or remove features is based 
on their statistical significance in a regression model. The method starts with 
zero features selected. For each candidate feature that has not been selected, 
the p-value of a student t-test of its coefficient (null hypothesis is that the 
coefficient is equal to zero) is calculated. For those features whose p-value is 
less than the entrance tolerance (α= 0.05), the coefficient with the smallest p-
value is selected. Of those features which have been selected, the feature that 
has the largest p-value and is also larger than the exit tolerance (α= 0.05) is 
removed. The process will be repeated until no improvement can be made, 
based on the significance test on the contribution of the candidate features. 
 
5.3.3.3 K-fold cross-validation 
To select the best features subsets and validate the performance of the 
proposed regression model, the available data should be classified into three 
parts; one part for training, one part for feature selection and one part for testing 
the performance. However, because of the limited number of subjects available, 
it is not feasible to classify the data into three groups and expect a reliable 
measure of performance. If all of the subjects are used in the training phase to 
obtain the model (weight vector β) which is subsequently used to estimate    , 
the MSE in (5.7) will typically be underestimated. This is due to the reason that 
the model is optimized to reduce the MSE of the training points, but not on 
unseen data points.  
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K-fold cross validation is a widely used method for estimating generalised future 
performance of statistical classification or regression models. It was used to 
estimate the error rate of the regression model in this study. K-fold method 
divides all the samples in equal sizes (if possible). The prediction function is 
learned using k-1 folds, and the fold left out is used for test. 
In this study, the data is divided into K=10 partitions containing an equal (or 
approximately equal) number of subjects. One of the partitions (the    part, k = 
1, 2, 3,…, K) is withheld as test subjects while the remaining K ─ 1 partitions 
are used to train the model. The MSE of the estimated    partition, MSE (k), is 
calculated. The procedure is repeated for K times and the cross validation error, 
CVerr, is calculated as the mean of the MSE for all the K parts, 
      
 
 
∑             (5.8) 
There are N! ways to allocate the subjects before dividing them into K parts. If a 
proper order was selected, the error rate can be small and misleading. To 
obtain a fairer approximation of the true error rate, this K-fold cross validation 
was repeated many times using different randomly selected partitions and the 
error rate is averaged across all repeats[152]. In the analysis, the repartitioning 
and cross-validation was repeated 2000 times. 
 
5.3.3.4 Model identification and verification 
The degree of agreement between the estimation method and the real 
measurements of CO and TPR was assessed using the Bland-Altman analysis 
method. The method has been proposed by Bland and Altman to compare the 
agreement of two clinical measurement methods in a series of publications 
[153-156] to determine whether these two methods can be used 
interchangeably or the new method can replace the established measurement. 
The basic concept of Bland-Altman’s approach is the visualization of the 
difference of the measurements made by the two methods, then plotting the 
differences (Y-axis) versus the mean of the two readings (X-axis). The 95% 
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limits of agreement are estimated as the mean difference (also known as bias) 
± 1.96×standard deviation (s.d.) of the differences, where 95% of the 
differences between the measurements are expected to lie. 
When the same subjects of two methods are repeatedly measured, the 
measurements by each method will be distributed about the expected 
measurement by that method for each subject. The difference between method 
means might change from subject to subject. In addition, the Bland-Altman 
analysis technique was enhanced to accommodate the analysis of repeated 
measurements of each clinical measurement method[156].When repeated 
measurements are taken using method X and Y, the variance of the difference 
(which directly affects the width of the limits of agreement) must be adjusted as 
follows: 
  
    ̅
  (  
 
  
)    
     
 
  
    
  (5.9) 
where   ̅ is the observed variance of the differences between the within-subject 
means,   and   is the number of measurements taken using methods X and 
Y, respectively,    
 and    
  are the within-subject variance (repeatability) of 
measurements taken using method X and Y, respectively. If the s.d. is 
estimated without adding the last two adjustment terms in equation, the s.d. will 
be underestimated. 
In this study, the repeated runs (2000 times) of the 10-fold cross-validation are 
assumed to be repeatedly measured from the same subject. If method X and Y 
are the measurement of LVO&TPR and the multivariate model output, 
respectively, then    =1 and   = 2000. The within-subject variance of method 
Y,    
  is calculated by taking the average of the 89 subjects of the estimated 
LVO&TPR of each subject across 2000 runs.   ̅  is the variance of the difference 
between the average of the estimated LVO&TPR (across 2000runs) and the 
measurement of LVO&TPR.   
  is approximately the sum of   ̅
  and    
  .Thus, 
  
  is expected to be large if the average of the 2000 estimations for each 
subject differs greatly from the real measurement of LVO and TPR or if the 
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estimated output differs greatly across each of the 2000 runs for a single 
subject. The s.d. is estimated using the square root of the right hand side of 
equation 5.9, whereby the repeatability of the model is taken into account. 
Furthermore, the performance of the model was compared using MSE and 
goodness of fit (  ) criteria. The    is given by: 
     
      
        
                                                                                              (5.10) 
where SSE is the sum of square of error given by  
       ∑    ̂   ̅ 
  
                                                                                     (5.11)  
         ∑      ̅ 
  
                                                                                   (5.12) 
where   ̅ is the mean value of the real measurement y ,   ̂  is the estimated 
output from the model. 
5.3.4 Results 
Modelling was performed on the LVO and TPR estimations from the 89 
measurements from preterm infants. Table 5-1 lists all the features in the 
feature pool and their associated number, which are used to reference the 
feature in the following discussions. Table 5-2 shows which features are 
selected by the feature search algorithm to estimate LVO and TPR, for each of 
the different starting feature subsets drawn from the entire feature pool. The 
bias (mean difference) and the precision (s.d. of the differences) of the 
estimation method when compared against the real measurements were 
calculated using the Bland-Altman analysis. 
Figure 5-8 and Figure 5-9 have shown the plots of the estimated variable 
plotted against the measured variable, along with the line of equality, for the 
selected LVO and TPR models, respectively. The Bland-Altman plot of the best 
LVO and TPR estimations are depicted in Figure 5-10 and Figure 5-11.   
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Figure 5-8: Plot of estimated LVO against measured LVO for all 89 subjects, 
with the line of equality. The value of the estimated LVO of each subject is 
represented by the average of the 2000 repeated estimations of the subject. 
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Figure 5-9: Plot of estimated TPR against measured TPR for all 89 subjects, 
with the line of equality. The value of the estimated TPR of each subject is 
represented by the average of the 2000 repeated estimations of the subject. 
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Figure 5-10: Bland-Altman plot of the LVO estimation.The solid line in the 
middle is the bias and the two lines above and below are the limits of 
agreement, calculated as bias±1.96×s.d.. Bias = -1.91m L/kg/ min, 1.96×s.d. = 
161.89 mL/kg/ min. 
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Figure 5-11: Bland-Altman plot of the TPR estimation.The solid line in the 
middle is the bias and the two lines above and below are the limits of 
agreement, calculated as bias±1.96×s.d.. Bias = 0.0002, 1.96×s.d. = 0.1411. 
  
0.05 0.1 0.15 0.2 0.25
-0.3
-0.2
-0.1
0
0.1
0.2
Bland-Altman plot for TPR estimation
Average of measured and estimated TPR
D
iff
e
re
n
c
e
 o
f 
m
e
a
s
u
re
d
 a
n
d
e
s
ti
m
a
te
d
 T
P
R
 
111 
 
Table 5-1: Feature pool and their respective reference numbers 
 
Feature 
 
x       Log(x) 
Diastolic decay  
rate(1/τ) 
1 7 13 19 
MAP 2 8 14 20 
HR 3 9 15 21 
Pulse 4 10 16 22 
MAP/τ 5 11 17 23 
PP × HR 6 12 18 24 
1/  : the diastolic decay rate.Each number represents a feature and the 
transformation (top headings) that is used. For example, feature 2, 14 and 21 
MAP,      and log (HR) respectively.  
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Table 5-2: LVO and TPR estimation performance and selected features 
Estimated  
variable 
        s.d. Feature pool 
LVO 
(mL/kg/min) 
0.71 -1.91 82.60 All features 
0.72 -1.77 82.80 
Diastolic decay rate 
features 
(1,7,13,19,5,11,17,23)  
0.71 -1.13 83.01 
Only linear features 
(exclude 7-24) 
TPR 
0.3680 0.0015 0.0720 All features 
0.5013 
 
0.0002 
 
0.0700 
Diastolic decay rate 
features 
(1,7,13,19,5,11,17,23) 
0.3759 0.0007 0.0725 
Only linear features 
(exclude 7-24) 
The features are selected by the stepwise feature selection algorithm to 
estimate LVO and TPR. The correlation   , Bland-Altman bias and s.d. 
achieved is shown.   
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5.3.5 Discussion 
In this study, multivariate regression models were developed to estimate LVO 
and TPR using a combination of features extracted from the PPG waveform, 
other routine cardiovascular measurements and the non-linear transformations 
of these features (quadratic and cubic powers and logarithm transform). The 
bias±precision (1.96×s.d.) for the best LVO model found -1.91±161.89 mL/kg/ 
min, and for the TPR model, the best bias precision achieved was.  
LVO estimation 
For CO estimation, previous study by Wang et al. has found the significant 
relationship between CO and the features selected from the 
photoplethysmogram (PPG) and ECG [14]. It has been proposed by Awad et al. 
to use multi-linear regression analysis to estimate CO from PPG features [157], 
but the precision was not sufficiently high for the clinical use. More recently, the 
achievements in the study of CO estimation showed that a reasonable estimate 
of CO can be obtained using only the PPG waveform. From the results of 
section 5.2.2, diastolic decay rate of ABP was found to have mild but significant 
relationships with LVO (r = 0.383, P = 0.0002).It should be noted here this is a 
direct correlation coefficient with LVO not subjected to the linear regression 
model. It was also found from this study that the utility of non-linear 
transformation on the features slightly improved the LVO estimation 
performance from -1.91  162.70 mL/kg/min to -1.13±161.90mL/kg/min.  
Furthermore, this study revealed that excluding diastolic decay rate of APB 
related features, i.e. MAP/τ and (1/τ), did not severely reduce the LVO 
estimation bias and precision (-1.77±162.29). This means that a reasonable 
estimate of LVO can be obtained using diastolic decay rate related features. 
TPR estimation 
TPR is a useful diagnostic tool of critical illness, for example, an increase in 
TPR may be a symptom of hemorrhagic shock in ischemic and hemorrhagic 
stroke patients[131] while a depression in TPR may be observed in anaphylaxis 
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patients. In the preterm infants, low TPR are symptoms of sepsis, which is a 
common cause of mortality and morbidity in preterm infants, particular those 
with very low birth weight  [22].Therefore, continuous monitoring of TPR has 
been suggested as a diagnostic and research tool to assist the vasoactive drug 
administration[158].The previous study has demonstrated the feasibility of 
deploying a multivariate regression to estimate SVR in the clinical diagnosis, 
using a non-invasive PPG signal.  
In this study, a quantitative estimation of TPR with bias precision of 0.0007±0. 
0.1421 was achieved using the multivariate regression model. If only the related 
features of diastolic decay rate of ABP were used in the model, the 
bias precision performance has been slightly improved to 0.0002 0.1372.  
5.3.6 Limitations 
One of the major limitations in this study is the ABP signal collection. The 
quality degradation caused by baseline drift, movement artefact and frequent 
ectopic beats  accounting for the  weak and unrecognizable BP pulses, which 
limited the length of data and the size of the data pool. 
The small data size was challenged in developing the multivariate model and 
the validation for estimating generalised performance of the regression models. 
Ideally, the model should be trained using as many samples as possible to 
reflect the true population, and the model should be tested using samples not 
which cannot be used in the training phase. In this study, this problem was 
addressed by repeatedly running 10-fold cross-validation to obtain a fair 
estimate of the generalised model performance.  
5.3.7 Summary 
This study provides a preliminary indication of the potential usefulness of a 
method to non-invasively estimate LVO and TPR using ABP signal. The limited 
results obtained encourage further research to validate the method in a larger 
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cohort, ultimately enabling a non-invasive, convenient and low-cost alternative 
for estimating or monitoring LVO and TPR.  
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Chapter 6. Conclusions and Future Work 
6.1 Summary 
This chapter concludes all of the research work that has been accomplished in 
this PhD project, which includes the development of cardiac output monitoring 
tools and signal processing methods for the clinical investigation of intra-
ventricular hemorrhage and other clinical risks of preterm infants. The 
performance of these new findings was analyzed based on data collected from 
actual patients, computer simulations and human experiments. 
The overall structure of the paper consisted of two main parts: The first part was 
based on developing monitoring tools to detect the IVH and other clinical 
risks.The use of spectral indices and detrended fluctuation analysis results, 
which were derived from the heart rate variability signals, the blood pressure 
variability and the cerebral near-infrared spectroscopy measures, to monitor the 
pathophysiologic response in cerebral cardiovascular control mechanisms 
produced intriguing results, showing distinctively difference between preterm 
infants with and without IVH . In fact, clinical investigation on IVH infants 
provided further supports to the findings. The outcomes of this research project 
may represent an important step towards a more thorough understanding of 
IVH progression, and may have substantial clinical implications of preterm 
infants.  
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Based on the previous CO monitoring of the preterm infants, the second part of 
the paper developed an initial attempt to apply arterial blood pressure  
waveform analysis to continuously monitor clinical risks in the preterm infants by 
estimating LVO and TPR, which produced encouraging regression results.  
The main findings of this PhD project are described in greater detail in the 
following section. 
6.2 Major findings of the current work 
 Chapter 3  
In this chapter, spectral and cross-spectral analysis was performed on 
HRV,   BPV   and NIRS measures such as HbO2, HHb, and tissue 
oxygenated index (TOI). In addition, indices related to cardiac baroreflex 
sensitivity and cerebral autoregulation were derived from the very low, low 
and mid frequency ranges (VLF, LF and MF). It was demonstrated that 
moderate correlations with CRIB II were identified from MAP normalised 
MF power, LF MAP-HHb coherence ,TOI VLF percentage power and LF 
baroreflex gain, with the latter two parameters also highly correlated with 
gestational age. The relationships between CRIB II and various spectral 
measures of arterial baroreflex and cerebral autoregulation functions have 
provided further justification for these measures as possible markers of 
clinical risks and predictors of adverse outcome in preterm infants. 
Also in the same demonstrated that the IVH infants were found to have 
significantly higher TOI, lower FTOE and lower coherence between arterial 
BP and HHb in the very low frequency range. These parameters can be 
utilised for non-invasive cerebral circulation monitoring of preterm infants 
and may help to completely understand the clinical utility of these NIRS 
measures for early identification of IVH. 
 Chapter 4  
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To further investigate potential method for clinical risk assessment, this 
paper utilized the detrended fluctuation analysis to quantify the fractal 
correlation properties of physiological signals. It has been examined 
whether DFA of the ABP signal could derive markers for the identification 
of preterm infants who developed IVH. DFA method was performed on the 
beat-to-beat sequences of MAP, SBP and pulse interval, with short-term 
exponent (α1, for time scale of 4-15 beats) and long-term exponent (α2, for 
time scale of 15-50 beats) computed accordingly. The IVH infants were 
found to have higher short-term scaling exponents of both MAP and SBP 
compared to the non-IVH. These identified scaling exponents of MAP and 
SBP have important implications on that fractal dynamics embedded in the 
arterial pressure waveform could provide useful information that facilitates 
early identification of IVH in preterm infants.  
 Chapter 5 
Lastly, this study investigated whether ABP waveform analysis could be 
useful for estimating left ventricular outflow and total peripheral resistance 
in preterm infants. The diastolic decay rate (1/τ) was obtained via fitting an 
exponential function to the last one third of each arterial pulse, with the 
mean rate computed from 50 pulses selected from each infant. This decay 
rate was considered to be inversely related to TPR while positively related 
to LVO. The results of regression analysis have confirmed that the diastolic 
decay rate had significant positive and negative relationships with LVO and 
TPR respectively. These preliminary results demonstrated the feasibility 
and applicability of arterial pressure waveform analysis for continuously 
estimating LVO and TPR in preterm infants. 
6.3  Future research directions 
In this section, some directions for future work extending this paper are 
presented: 
Chapter 3 
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 The cerebral NIRS measurement based monitoring tool proposed in the 
current work has shown a number of parameters that were potentially 
distinguishing between preterm infants with or without brain haemorrhage, 
further studies with larger sample size are warranted for a more complete 
understanding of the clinical utility of these NIRS measures for early 
identification of IVH infants.   
 
 The relationships between CRIB II and various spectral measures of 
arterial baroreflex and cerebral autoregulation functions have provided 
further justification for these measures as possible markers of clinical risks 
and predictors of adverse outcome in preterm infants. Future studies can 
focus on relating more clinical measure to the CRIB II or other established 
clinical risk score to support the diagnosis of serious illness in preterm 
infants. 
 
Chapter 4 
 The results showed that the IVH infants had higher short-term scaling 
exponents of both MAP and SBP compared to the non-IVH infants. 
Thus, fractal dynamics in arterial BP could provide potentially useful 
information that facilitates early identification of IVH in preterm infants. 
Further studies should include more preterm infants with IVH to assess 
how the DFA exponents relate to the severity of haemorrhage. 
 
 Based on the previous literature, it is assumed that other nonlinear 
analysis of NIRS measures, BP signals will provide potentially useful 
information to classify IVH in preterm infants.  
 
 
 DFA methods can be applied in conjunction with the commonly used 
spectral analysis method to provide a more complete picture of the 
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underlying cardiovascular dynamics, as both methods can provide 
complementary information. 
 
 In this study, with the limited number of infants without mechanical 
ventilation for statistical analysis, whether the ventilatory mode had any 
direct impact on the results would need to be addressed by further 
studies with larger sample size. 
 
 The performance of the proposed cardiovascular indices from DFA 
method and multi-parameter classification model in the classification of 
IVH should be assessed in a prospective clinical trial, with the inclusion 
of larger sample size of preterm infants in our cohort.  
 
 Advanced dynamical models can be used for estimation of transient 
behaviour of blood pressure and other physiological variables in real 
time [159-163], which might be potentially applied to prevent IVH in 
preterm infants. 
 
 
Chapter 5 
 Multivariate regression model in the estimation of LVO and TPR should 
be further assessed with the inclusion of larger sample size study, to 
validate the usefulness of monitoring in clinical decision-making. 
 
 Improve the input features of the regression model, such as frequency 
analysis and DFA methods results to build the control system to 
manage the mechanical ventilation in the neonatal ICU. 
 
 A promising new research direction is the estimation of LVO and TPR 
by applying a method of robust Kalman filtering [164-170]. 
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The suggestions above are examples of possible future research based on 
the results presented in this paper. 
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